TLK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NMY6 | S127 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| A6NMY6 | T123 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| O00115 | S57 | Sugiyama | DNASE2 DNASE2A DNL2 | ALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGR |
| O00115 | S58 | Sugiyama | DNASE2 DNASE2A DNL2 | LRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEGAVGRS |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00592 | T556 | Sugiyama | PODXL PCLP PCLP1 | DsWIVPLDNLTKDDLDEEEDtHL__________________ |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O15355 | S349 | Sugiyama | PPM1G PPM1C | tTAVVALIRGKQLIVANAGDsRCVVsEAGKALDMsyDHKPE |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43670 | S371 | Sugiyama | ZNF207 BUGZ | PATLTTtsAtsKLIHPDEDIsLEERRAQLPKYQRNLPRPGQ |
| O43719 | S702 | Sugiyama | HTATSF1 | EDADGKEVEDADEKLFEDDDsNEKLFDEEEDssEKLFDDsD |
| O43719 | S713 | Sugiyama | HTATSF1 | DEKLFEDDDsNEKLFDEEEDssEKLFDDsDERGTLGGFGSV |
| O43823 | T316 | Sugiyama | AKAP8 AKAP95 | FGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGD |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O43852 | T177 | Sugiyama | CALU | ERRFKMADKDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtM |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T254 | Sugiyama | CALU | REQFVEFRDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLV |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60271 | T418 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | DEGADLLGMGREVENLILENtQLLEtKNALNIVKNDLIAKV |
| O60566 | T608 | Sugiyama | BUB1B BUBR1 MAD3L SSK1 | SEDAIITGFRNVtICPNPEDtCDFARAARFVStPFHEIMSL |
| O60610 | S542 | Sugiyama | DIAPH1 DIAP1 | ALHSEKQQIATEKQDLEAEVsQLtGEVAKLTKELEDAKKEM |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O60934 | S738 | Sugiyama | NBN NBS NBS1 P95 | ELEEWLRQEMEVQNQHAKEEsLADDLFRyNPyLKRRR____ |
| O75410 | S276 | Sugiyama | TACC1 KIAA1103 | GtPLPKAsYHFsPEELDENtsPLLGDARFQKsPPDLKETPG |
| O75410 | T275 | Sugiyama | TACC1 KIAA1103 | EGtPLPKAsYHFsPEELDENtsPLLGDARFQKsPPDLKETP |
| O75436 | T102 | Sugiyama | VPS26A VPS26 | KSNTHEFVNLVKELALPGELtQSRSYDFEFMQVEKPYESYI |
| O75717 | S383 | Sugiyama | WDHD1 AND1 | LMMAsGRPRQRsHILEDDENsVDIsMLKtGssLLKEEEEDG |
| O75821 | T206 | Sugiyama | EIF3G EIF3S4 | LGLstGEKEKLPGELEPVQAtQNKtGKYVPPsLRDGAsRRG |
| O94763 | T447 | Sugiyama | URI1 C19orf2 NNX3 PPP1R19 RMP URI | SAAEFDDRRGVLRsIsCEEAtCsDtsEsILEEEPQENQKKL |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95433 | T20 | Sugiyama | AHSA1 C14orf3 HSPC322 | _MAKWGEGDPRWIVEERADAtNVNNWHWtERDASNWSTDKL |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04080 | T96 | Sugiyama | CSTB CST6 STFB | ENKPLtLsNyQTNKAKHDELtyF__________________ |
| P04150 | S125 | Sugiyama | NR3C1 GRL | PQQGQISLSSGETDLKLLEEsIANLNRstsVPENPKSSAST |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04920 | S56 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | DELHRTLGVERFEEILQEAGsRGGEEPGRsYGEEDFEyHRQ |
| P05198 | T284 | Sugiyama | EIF2S1 EIF2A | EKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVDGDD |
| P05362 | S88 | Sugiyama | ICAM1 | ELLLPGNNRKVYELSNVQEDsQPMCYSNCPDGQSTAKTFLT |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T335 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | VRLITLEEEMTKyKPEsEELtAERItEFCHRFLEGKIKPHL |
| P07237 | T462 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | tLKFFPAsADRtVIDyNGERtLDGFKKFLESGGQDGAGDDD |
| P07355 | S127 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEINRVy |
| P07355 | T123 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07711 | S329 | Sugiyama | CTSL CTSL1 | GGyVKMAKDRRNHCGIAsAAsyPtV________________ |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08174 | T59 | Sugiyama | CD55 CR DAF | PPDVPNAQPALEGRTsFPEDtVItyKCEEsFVKIPGEKDsV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08621 | S410 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | DEARGGGGGQDNGLEGLGNDsRDMYMESEGGDGYLAPENGY |
| P08670 | T202 | Sugiyama | VIM | IMRLREKLQEEMLQREEAENtLQsFRQDVDNAsLARLDLER |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09493 | T282 | Sugiyama | TPM1 C15orf13 TMSA | AQKLKYKAISEELDHALNDMtsI__________________ |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | T123 | Sugiyama | ALDOC ALDC | IVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGA |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | S54 | Sugiyama | TUBA3C TUBA2 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11387 | S10 | Sugiyama | TOP1 | ___________MsGDHLHNDsQIEADFRLNDsHKHKDKHKD |
| P13073 | S34 | Sugiyama | COX4I1 COX4 | AISTSVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKH |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T134 | Sugiyama | PRKCSH G19P1 | NtCKEKGRKEREsLQQMAEVtREGFRLKKILIEDWKKAREE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14854 | S52 | Sugiyama | COX6B1 COX6B | QNyLDFHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTD |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | T583 | Sugiyama | NCL | sPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTD |
| P20042 | T31 | Sugiyama | EIF2S2 EIF2B | tMsKKKKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtED |
| P20042 | T33 | Sugiyama | EIF2S2 EIF2B | sKKKKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtEDKD |
| P20042 | T36 | Sugiyama | EIF2S2 EIF2B | KKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtEDKDLEA |
| P20810 | S295 | Sugiyama | CAST | QEKKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEV |
| P20810 | S297 | Sugiyama | CAST | KKRKVEKDtMsDQALEALsAsLGTRQAEPELDLRsIKEVDE |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23526 | T157 | Sugiyama | AHCY SAHH | NLIHTKYPQLLPGIRGIsEEtTTGVHNLyKMMANGILKVPA |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P25205 | S704 | Sugiyama | MCM3 | DQEQKRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P27797 | S214 | Sugiyama | CALR CRTC | GsLEDDWDFLPPKKIKDPDAsKPEDWDERAKIDDPtDsKPE |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | S643 | Sugiyama | MAP4 | IsPEtVTGtGKKCsLPAEEDsVLEKLGERKPCNsQPSELSS |
| P27816 | T57 | Sugiyama | MAP4 | VVGETVGKTDyIPLLDVDEKtGNsESKKKPCsEtsQIEDtP |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30040 | T62 | Sugiyama | ERP29 C12orf8 ERP28 | DtVtFyKVIPKSKFVLVKFDtQyPyGEKQDEFKRLAENSAS |
| P30086 | T101 | Sugiyama | PEBP1 PBP PEBP | YREWHHFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyV |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31153 | T240 | Sugiyama | MAT2A AMS2 MATA2 | DALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAG |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34932 | S414 | Sugiyama | HSPA4 APG2 HSPH2 | ITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTF |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S169 | Sugiyama | MYH9 | HIyAITDtAyRSMMQDREDQsILCTGESGAGKTENTKKVIQ |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1745 | Sugiyama | MYH9 | RRLEARIAQLEEELEEEQGNtELINDRLKKANLQIDQINtD |
| P35579 | T1827 | Sugiyama | MYH9 | AsITALEAKIAQLEEQLDNEtKERQAACKQVRRTEKKLKDV |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35580 | T1158 | Sugiyama | MYH10 | EKQKRDLsEELEALKTELEDtLDTTAAQQELRTKREQEVAE |
| P35580 | T1433 | Sugiyama | MYH10 | LAYDKLEKTKNRLQQELDDLtVDLDHQRQVASNLEKKQKKF |
| P35580 | T1718 | Sugiyama | MYH10 | SsERARRHAEQERDELADEItNSASGKSALLDEKRRLEARI |
| P35637 | S462 | Sugiyama | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P35659 | S227 | Sugiyama | DEK | ERNsSGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDE |
| P35659 | S231 | Sugiyama | DEK | SGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDEDKEs |
| P35659 | S306 | Sugiyama | DEK | DSSTTKKNQNSSKKEsEsEDssDDEPLIKKLKKPPTDEELK |
| P36954 | S73 | Sugiyama | POLR2I | IyVNKITHEVDELtQIIADVsQDPTLPRTEDHPCQKCGHKE |
| P36954 | T66 | Sugiyama | POLR2I | QEADNSCIyVNKITHEVDELtQIIADVsQDPTLPRTEDHPC |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38398 | S395 | Sugiyama | BRCA1 RNF53 | LNssIQKVNEWFSRSDELLGsDDsHDGEsESNAKVADVLDV |
| P38398 | S398 | Sugiyama | BRCA1 RNF53 | sIQKVNEWFSRSDELLGsDDsHDGEsESNAKVADVLDVLNE |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39687 | T126 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | IEPLKKLENLKsLDLFNCEVtNLNDyRENVFKLLPQLtyLD |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P43121 | T299 | Sugiyama | MCAM MUC18 | PPHFSISKQNPstREAEEEttNDNGVLVLEPARKEHSGRYE |
| P46013 | T1972 | Sugiyama | MKI67 | EDLAGFKELFQtPGHtEEsMtDDKITEVsCKsPQPDPVKtP |
| P46013 | T2093 | Sugiyama | MKI67 | LEDLAGFKELFQtPDHTEESttDDKTTKIACKsPPPEsMDt |
| P46013 | T896 | Sugiyama | MKI67 | GRSTEFRNIQKLPVESKSEEtNTEIVECILKRGQKATLLQQ |
| P46087 | S40 | Sugiyama | NOP2 NOL1 NSUN1 | KQKGAEtELVRFLPAVsDENsKRLsSRARKRAAKRRLGsVE |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46937 | S382 | Sugiyama | YAP1 YAP65 | QNPVssPGMsQELRTMttNssDPFLNsGtyHsRDEstDsGL |
| P46937 | S403 | Sugiyama | YAP1 YAP65 | DPFLNsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEM |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49790 | S94 | Sugiyama | NUP153 | EVPRWPENKEDHLVYADEESsNITDGRItPEPAVSNTEEPS |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | T412 | Sugiyama | GDI2 RABGDIB | LGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFE |
| P50552 | T331 | Sugiyama | VASP | EKNstTLPRMKssssVttsEtQPCtPsSSDySDLQRVKQEL |
| P52272 | S633 | Sugiyama | HNRNPM HNRPM NAGR1 | GGGGAsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKAC |
| P52272 | S637 | Sugiyama | HNRNPM HNRPM NAGR1 | AsFDRAIEMERGNFGGsFAGsFGGAGGHAPGVARKACQIFV |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P52948 | T687 | Sugiyama | NUP98 ADAR2 | IPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEGssEE |
| P52948 | T822 | Sugiyama | NUP98 ADAR2 | YLDDNQKPPVGEGLNRKAEVtLDGVWPTDKTSRCLIKsPDR |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P54105 | S42 | Sugiyama | CLNS1A CLCI ICLN | DTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEYPTIS |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P55196 | S1510 | Sugiyama | AFDN AF6 MLLT4 | IERRDLQyItVsKEELssGDsLsPDPWKRDAKEKLEKQQQM |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61353 | T33 | Sugiyama | RPL27 | VLAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKV |
| P61604 | S21 | Sugiyama | HSPE1 | MAGQAFRKFLPLFDRVLVERsAAETVTKGGIMLPEKSQGKV |
| P61604 | T79 | Sugiyama | HSPE1 | EIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDILGK |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62495 | S295 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | LSNVKFIQEKKLIGRyFDEIsQDtGKyCFGVEDTLKALEMG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62854 | S57 | Sugiyama | RPS26 | KKFVIRNIVEAAAVRDIsEAsVFDAyVLPKLYVKLHYCVSC |
| P62857 | S39 | Sugiyama | RPS28 | GRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLL |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | S54 | Sugiyama | TUBA1B | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | S11 | SIGNOR|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q01082 | S2115 | Sugiyama | SPTBN1 SPTB2 | ERKRRPPsPEPstKVsEEAEsQQQWDtsKGEQVsQNGLPAE |
| Q01082 | S35 | Sugiyama | SPTBN1 SPTB2 | QQQYSDVNNRWDVDDWDNENsSARLFERSRIKALADEREAV |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S165 | Sugiyama | SET | PyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQ |
| Q02952 | T577 | Sugiyama | AKAP12 AKAP250 | sQEEQKGEssAssPEEPEEItCLEKGLAEVQQDGEAEEGAt |
| Q04721 | T132 | Sugiyama | NOTCH2 | SRPCLNGGTCHMLSRDtyECtCQVGFTGKECQWTDACLSHP |
| Q04760 | T112 | Sugiyama | GLO1 | ALSRKATLELTHNWGtEDDEtQsyHNGNsDPRGFGHIGIAV |
| Q05682 | S129 | Sugiyama | CALD1 CAD CDM | KRLQEALERQKEFDPtItDAsLsLPsRRMQNDTAENETTEK |
| Q05682 | S131 | Sugiyama | CALD1 CAD CDM | LQEALERQKEFDPtItDAsLsLPsRRMQNDTAENETTEKEE |
| Q05682 | T86 | Sugiyama | CALD1 CAD CDM | VEVNAQNsVPDEEAKTTtTNtQVEGDDEAAFLERLARREER |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07157 | S1064 | Sugiyama | TJP1 ZO1 | PYVEKQAsRDLEQPtyRyEsssytDQFsRNYEHRLRYEDRV |
| Q07157 | S1680 | Sugiyama | TJP1 ZO1 | QGAIPEGVEQEIYFKVCRDNsILPPLDKEKGETLLSPLVMC |
| Q09666 | S1170 | Sugiyama | AHNAK PM227 | LPKADVVVSGPKVDIEAPDVsLEGPEGKLKGPKFKMPEMHF |
| Q09666 | T146 | Sugiyama | AHNAK PM227 | ttKIKPRLKsEDGVEGDLGEtQsRTITVTRRVtAytVDVTG |
| Q09666 | T38 | Sugiyama | AHNAK PM227 | sGsHGLTIAQRDDGVFVQEVtQNsPAARTGVVKEGDQIVGA |
| Q12805 | T219 | Sugiyama | EFEMP1 FBLN3 FBNL | CQCPPGYQKRGEQCVDIDECtIPPYCHQRCVNTPGSFYCQC |
| Q13155 | S48 | Sugiyama | AIMP2 JTV1 PRO0992 | PNVHGRSyGPAPGAGHVQEEsNLsLQALESRQDDILKRLYE |
| Q13242 | T177 | Sugiyama | SRSF9 SFRS9 SRP30C | DMEYALRKLDDTKFRsHEGEtsYIRVYPERstsYGYsRsRS |
| Q13263 | S501 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LMRKVPRVsLERLDLDLtADsQPPVFKVFPGsttEDyNLIV |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13596 | S229 | Sugiyama | SNX1 | PPPPEKSLIGMTKVKVGKEDsssAEFLEKRRAALERYLQRI |
| Q13765 | S132 | Sugiyama | NACA HSD48 | YKSPAsDtyIVFGEAKIEDLsQQAQLAAAEKFKVQGEAVsN |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14151 | S207 | Sugiyama | SAFB2 KIAA0138 | FKNtLEtssLNFKVtPDIEEsLLEPENEKILDILGEtCKsE |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14157 | S855 | Sugiyama | UBAP2L KIAA0144 NICE4 | ysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAP |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14157 | T863 | Sugiyama | UBAP2L KIAA0144 NICE4 | ttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTLAQPQ |
| Q14247 | S331 | Sugiyama | CTTN EMS1 | GVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIR |
| Q14247 | T328 | Sugiyama | CTTN EMS1 | GKyGVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKts |
| Q14257 | T137 | Sugiyama | RCN2 ERC55 | VTWDEyNIQMyDRVIDFDENtALDDAEEEsFRKLHLKDKKR |
| Q14444 | T103 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | NKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMALsQDI |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14498 | S336 | Sugiyama | RBM39 HCC1 RNPC2 | LAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGR |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14671 | S180 | Sugiyama | PUM1 KIAA0099 PUMH1 | KDGPKGIFLGDQWRDsAWGTsDHsVsQPIMVQRRPGQsFHV |
| Q14671 | S185 | Sugiyama | PUM1 KIAA0099 PUMH1 | GIFLGDQWRDsAWGTsDHsVsQPIMVQRRPGQsFHVNsEVN |
| Q14676 | S498 | Sugiyama | MDC1 KIAA0170 NFBD1 | RALVRAHsEKDQPPFGDsDDsVEADKssPGIHLERsQAstt |
| Q14676 | S763 | Sugiyama | MDC1 KIAA0170 NFBD1 | LDEPWEVLATQPFCLREsEDsEtQPFDtHLEAyGPCLsPPR |
| Q14676 | T765 | Sugiyama | MDC1 KIAA0170 NFBD1 | EPWEVLATQPFCLREsEDsEtQPFDtHLEAyGPCLsPPRAI |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14978 | S643 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | sPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGERANQVLK |
| Q14980 | S1181 | Sugiyama | NUMA1 NMP22 NUMA | DsALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQD |
| Q15047 | S86 | Sugiyama | SETDB1 ESET KIAA0067 KMT1E | TWVIQKESEVAHVDQLFDDAsRAVTNCEsLVKDFYSKLGLQ |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15185 | S118 | Sugiyama | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q15293 | S158 | Sugiyama | RCN1 RCN | EEyKQAtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAA |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q15293 | T318 | Sugiyama | RCN1 RCN | EKLTKEEILENWNMFVGsQAtNyGEDLtKNHDEL_______ |
| Q15293 | T325 | Sugiyama | RCN1 RCN | ILENWNMFVGsQAtNyGEDLtKNHDEL______________ |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q15527 | T184 | Sugiyama | SURF2 | DDsMtDLYPPELFTRKDLGstEDGDGtDDFLtDKEDEKAKP |
| Q15650 | S341 | Sugiyama | TRIP4 RQT4 | RLSKKVTIDFAGRKILEEENsLAEyHSRLDETIQAIANGTL |
| Q15652 | T513 | Sugiyama | JMJD1C JHDM2C KIAA1380 TRIP8 | LLPKEKFVSRPPtPKCVIDItNDtNLEKVAQENSSTFGLQT |
| Q15652 | T516 | Sugiyama | JMJD1C JHDM2C KIAA1380 TRIP8 | KEKFVSRPPtPKCVIDItNDtNLEKVAQENSSTFGLQTLQK |
| Q16513 | S19 | Sugiyama | PKN2 PRK2 PRKCL2 | __MAsNPERGEILLTELQGDsRsLPFSENVsAVQKLDFsDt |
| Q16513 | S591 | Sugiyama | PKN2 PRK2 PRKCL2 | EPEPPPAPPRAssLGEIDEssELRVLDIPGQDsEtVFDIQN |
| Q16513 | T605 | Sugiyama | PKN2 PRK2 PRKCL2 | GEIDEssELRVLDIPGQDsEtVFDIQNDRNsILPKsQsEyK |
| Q16513 | T951 | Sugiyama | PKN2 PRK2 PRKCL2 | PPFIPTIRGREDVSNFDDEFtsEAPILtPPREPRILsEEEQ |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q16531 | T1137 | Sugiyama | DDB1 XAP1 | GSGMKREAtADDLIKVVEELtRIH_________________ |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32MZ4 | T477 | Sugiyama | LRRFIP1 GCF2 TRIP | MVEVPQELEtstGHsLEKEFtNQEAAEPKEVPAHsTEVGRD |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q4V328 | S666 | Sugiyama | GRIPAP1 KIAA1167 | EELVLsEMNsPSRtQtGDsssIssFsYREILREKEssAVPA |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q5JSH3 | S71 | Sugiyama | WDR44 RPH11 | PVQELKQDVSKKIIEsIIEEsQKVLQLEDDsLDSKGKELsD |
| Q5JSH3 | S81 | Sugiyama | WDR44 RPH11 | KKIIEsIIEEsQKVLQLEDDsLDSKGKELsDQAtAsPIVAR |
| Q5QJE6 | T241 | Sugiyama | DNTTIP2 ERBP TDIF2 | IVPGNEKQIVGtPVNsEDsDtRQtsHLQARsLsEINKPNFY |
| Q5QJE6 | T244 | Sugiyama | DNTTIP2 ERBP TDIF2 | GNEKQIVGtPVNsEDsDtRQtsHLQARsLsEINKPNFYNND |
| Q5RKV6 | S14 | Sugiyama | EXOSC6 MTR3 | _______MPGDHRRIRGPEEsQPPQLyAADEEEAPGTRDPT |
| Q5T200 | S1382 | Sugiyama | ZC3H13 KIAA0853 | LIsDsVERDRDRDRDRTFESsQIEsVKRCEAKLEGEHERDL |
| Q5UIP0 | S1810 | Sugiyama | RIF1 | EHHsVNFHLGLKEDNDtINDsLIVSETKSKENTMQEsLPSG |
| Q5UIP0 | T1806 | Sugiyama | RIF1 | QFLDEHHsVNFHLGLKEDNDtINDsLIVSETKSKENTMQEs |
| Q5VTR2 | S138 | Sugiyama | RNF20 BRE1A | GDLLTERKALVVPEPEPDsDsNQERKDDRERGEGQEPAFSF |
| Q6FI81 | T250 | Sugiyama | CIAPIN1 CUA001 PRO0915 | ASLRAASCGEGKKRKACKNCtCGLAEELEKEKSREQMSSQP |
| Q6P996 | S721 | Sugiyama | PDXDC1 KIAA0251 | LPGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQ |
| Q6P996 | S722 | Sugiyama | PDXDC1 KIAA0251 | PGQKPFKRsLRGsDALsEtssVsHIEDLEKVERLssGPEQI |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | S54 | Sugiyama | TUBA3E | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | S54 | Sugiyama | TUBA1A TUBA3 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7LBC6 | S314 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | GCDPASKKLKGDRGEVDsNGsDGGEAsRGPWKGGNASGEPG |
| Q7LBC6 | S320 | Sugiyama | KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 | KKLKGDRGEVDsNGsDGGEAsRGPWKGGNASGEPGLDQRAK |
| Q7Z3K3 | S28 | Sugiyama | POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 | MECEEEELEPWQKISDVIEDsVVEDyNsVDKTTTVSVSQQP |
| Q7Z3T8 | S319 | Sugiyama | ZFYVE16 KIAA0305 | TSALTCSLPKNEDLCLNDsNsRDENFKLPDFsFQEDKTVIK |
| Q7Z417 | S608 | Sugiyama | NUFIP2 KIAA1321 PIG1 | sGALsLEPsHIGDLQKADtssQGALVFLSKDYEIEsQNPLA |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z417 | T117 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LNGNAGEREISLKNLssDEAtNPIsRVLNGNQQVVDTsLKQ |
| Q7Z417 | T606 | Sugiyama | NUFIP2 KIAA1321 PIG1 | sEsGALsLEPsHIGDLQKADtssQGALVFLSKDYEIEsQNP |
| Q86SQ0 | S719 | Sugiyama | PHLDB2 LL5B | SMREQLQQQLKRDADLLDVEsKHFEDLEFQQLEHESRLDEE |
| Q86TU7 | S505 | Sugiyama | SETD3 C14orf154 | NREYYRQQMEEKAPLPKyEEsNLGLLEssVGDSRLPLVLRN |
| Q86UE4 | S323 | Sugiyama | MTDH AEG1 LYRIC | KWNsVsPAsAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDR |
| Q86UE4 | T326 | Sugiyama | MTDH AEG1 LYRIC | sVsPAsAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDRsIF |
| Q86UE4 | T331 | Sugiyama | MTDH AEG1 LYRIC | sAGKRKtEPSAWsQDtGDANtNGKDWGRsWsDRsIFsGIGs |
| Q86UE8 | S686 | Sugiyama | TLK2 | SVGVIFYQCLYGRKPFGHNQsQQDILQENtILKATEVQFPP |
| Q86UE8 | T695 | Sugiyama | TLK2 | LYGRKPFGHNQsQQDILQENtILKATEVQFPPKPVVTPEAK |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q8IUD2 | S824 | Sugiyama | ERC1 ELKS KIAA1081 RAB6IP2 | KKKsAQMLEEARRREDNLNDsSQQLQDSLRKKDDRIEELEE |
| Q8IW41 | S160 | SIGNOR|PSP | MAPKAPK5 PRAK | HLLNIAHRDLKPENLLFKDNsLDAPVKLCDFGFAKIDQGDL |
| Q8IW41 | S354 | SIGNOR|PSP | MAPKAPK5 PRAK | AEQLANMRIQDLKVSLKPLHsVNNPILRKRKLLGTKPKDSV |
| Q8IW41 | S386 | SIGNOR|PSP | MAPKAPK5 PRAK | LGTKPKDSVYIHDHENGAEDsNVALEKLRDVIAQCILPQAG |
| Q8N1G0 | S316 | Sugiyama | ZNF687 KIAA1441 | KSSPGsPQSPSSGAEAADEDsNDSPASSSSRPLKVRIKTIK |
| Q8N6T3 | T291 | Sugiyama | ARFGAP1 ARF1GAP | GVsQLAsKVQGVGSKGWRDVttFFsGKAEGPLDsPSEGHSy |
| Q8N6T3 | T354 | Sugiyama | ARFGAP1 ARF1GAP | SAEPTKtRKsPssDsWtCADtstERRssDsWEVWGSASTNR |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8NEF9 | S279 | Sugiyama | SRFBP1 | EYFDDstEERFYKQSsMSEDsDsGDDFFIGKVRRTRKKESS |
| Q8NEM2 | S42 | Sugiyama | SHCBP1 | GWAVEQELASLEKGLFQDEDsCsDCsYRDKPGssLQSFMPE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TEW0 | S840 | Sugiyama | PARD3 PAR3 PAR3A | REGFGRQsMsEKRtKQFsDAsQLDFVKTRKsKsMDLGIADE |
| Q8WU90 | T348 | Sugiyama | ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 | sVNDIDLSLYIPRDVDEtGItVAsLERFSTYTsDKDENKLs |
| Q8WUA2 | S425 | Sugiyama | PPIL4 | KNTNQDIYREMGFGHYEEEEsCWEKQKSEKRDRTQNRSRSR |
| Q8WUD4 | S149 | Sugiyama | CCDC12 | KRTQRAIAELIRERLKGQEDsLAsAVDAATEQKtCDsD___ |
| Q8WVC0 | S72 | Sugiyama | LEO1 RDL | DSGQPSNKELFGDDsEDEGAsHHsGSDNHSERSDNRsEAsE |
| Q8WWI1 | S1177 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | SESLQSSNIESKEINGIHDEsNAFEsKASEsISLKNLKRRs |
| Q8WWI1 | S1410 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RIYQYRRPVDsyDIPKTEEAsSGFLPGDRNKsRsttELDDY |
| Q8WWM7 | S563 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | EELRKFGAQFKLQPsssPENsLDPFPPRILKEEPKGKEKEV |
| Q92688 | T126 | Sugiyama | ANP32B APRIL PHAPI2 | LEPLKKLECLKsLDLFNCEVtNLNDyREsVFKLLPQLTYLD |
| Q92785 | S142 | Sugiyama | DPF2 BAF45D REQ UBID4 | LLRTDPLEKRGAPDPRVDDDsLGEFPVTNsRARKRILEPDD |
| Q92974 | S953 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | PEERLQDssDPDtGsEEEGssRLsPPHsPRDFtRMQDIPEE |
| Q92974 | S976 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sPPHsPRDFtRMQDIPEEtEsRDGEAVASES__________ |
| Q969U7 | S166 | Sugiyama | PSMG2 HCCA3 PAC2 TNFSF5IP1 | SMQKSVQNKIKSLNWEEMEKsRCIPEIDDSEFCIRIPGGGI |
| Q96AY4 | T2170 | Sugiyama | TTC28 KIAA1043 TPRBK | QEESNPKLDPQELAQKILEEtQSHLIAVERLQRSGGQVSKS |
| Q96B36 | T233 | Sugiyama | AKT1S1 PRAS40 | PDLDRIAAsMRALVLREAEDtQVFGDLPRPRLNtsDFQKLK |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96G46 | T82 | Sugiyama | DUS3L | PAGNELAEPEAKRIRLEDGQtADGQtEEAAEPGEQLQtQKR |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96PY6 | S14 | EPSD|PSP | NEK1 KIAA1901 | _______MEKYVRLQKIGEGsFGKAILVKstEDGRQYVIKE |
| Q96PY6 | T141 | SIGNOR|EPSD|PSP | NEK1 KIAA1901 | DRKILHRDIKSQNIFLTKDGtVQLGDFGIARVLNstVELAR |
| Q96PY6 | Y315 | EPSD|PSP | NEK1 KIAA1901 | sGQNsISVMPAQKITKPAAKyGIPLAyKKYGDKKLHEKKPL |
| Q99638 | S328 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | RAD9A | IAMETTIGNEGSRVLPsIsLsPGPQPPKsPGPHsEEEDEAE |
| Q99638 | T355 | SIGNOR|EPSD|PSP | RAD9A | KsPGPHsEEEDEAEPStVPGtPPPKKFRsLFFGsILAPVRs |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | S54 | Sugiyama | TUBA1C TUBA6 | GQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtV |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BRK5 | T193 | Sugiyama | SDF4 CAB45 PSEC0034 | SEKEVADAIRLNEELKVDEEtQEVLENLKDRWYQADsPPAD |
| Q9BRQ0 | S349 | Sugiyama | PYGO2 PP7910 | PCGACRSEVNDDQDAILCEAsCQKWFHRECTGMTESAYGLL |
| Q9BRS2 | S21 | Sugiyama | RIOK1 RIO1 | MDYRRLLMSRVVPGQFDDADssDsENRDLKTVKEKDDILFE |
| Q9BSJ8 | S1086 | Sugiyama | ESYT1 FAM62A KIAA0747 MBC2 | MsRERELLGKVQLDLAETDLsQGVARWYDLMDNKDKGss__ |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BY43 | T98 | Sugiyama | CHMP4A C14orf123 SHAX2 CDA04 HSPC134 | QTDGtLStLEFQREAIENATtNAEVLRTMELAAQSMKKAYQ |
| Q9BYW2 | S968 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | NRRNNGLSGKCLQEAQEEGNsILPERRGRPEISLDERGEGG |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9C086 | S127 | Sugiyama | INO80B HMGA1L4 PAPA1 ZNHIT4 | EEEPMEGVPLEQYRAWLDEDsNLsPsPLRDLsGGLGGQEEE |
| Q9C0C2 | S1046 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GLFsPstAHVPDGALGQRDQssWQNsDAsQEVGGHQERQQA |
| Q9C0C2 | S1054 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | HVPDGALGQRDQssWQNsDAsQEVGGHQERQQAGAQGPGsA |
| Q9C0C2 | S1331 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | WGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMDWTQDLAPQ |
| Q9C0C2 | S1371 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QNVELFGAPSEAREHGVGGVsQCPEPGLRHNGsLsPGLEAR |
| Q9C0C2 | S806 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | STREWASRCGIGQEEMEAsSsQDQSKVSAPGVLTAQDRVVG |
| Q9C0C2 | S882 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LQDQEFGKRDsLGtyssRDVsLGDWEFGKRDsLGAyAsQDA |
| Q9C0C2 | S936 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GRyssQDADEQDWEFQKRDVsLGTyGSRAAEPQEQEFGKSA |
| Q9C0C2 | T1228 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | CLESGGSEEPGGIGVGEKDWtsDVNVKSKDLAEVGEGGGHs |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9GZV5 | S296 | Sugiyama | WWTR1 TAZ | QAAVNPPTMtPDMRSItNNssDPFLNGGPyHsREQsTDsGL |
| Q9H3Q1 | T314 | Sugiyama | CDC42EP4 BORG4 CEP4 | GsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPDRARAA |
| Q9H425 | T300 | Sugiyama | C1orf198 | PsQLEGKLPsPDVRQDDGEDtLFSEPKFAQVSSSNVVLKTG |
| Q9H444 | T101 | Sugiyama | CHMP4B C20orf178 SHAX1 | QIDGtLstIEFQREALENANtNtEVLKNMGYAAKAMKAAHD |
| Q9H4L7 | S239 | Sugiyama | SMARCAD1 KIAA1122 | EDEFNDDQSIKKtRLDHGEEsNEsAEsSsNWEKQESIVLKL |
| Q9H501 | S79 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | PISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIKKKKT |
| Q9H788 | S159 | Sugiyama | SH2D4A PPP1R38 SH2A | NQQtKDIWKKVAEKEELEQGsRPAPTLEEEKIRSLSSSSRN |
| Q9H814 | T49 | Sugiyama | PHAX RNUXA | LQLPKVLGGDsAMRAFQNTAtACAPVSHyRAVESVDSSEES |
| Q9H8T0 | S237 | PSP | AKTIP FTS | VKVCTARLFDQPKIEDPYAIsFSPWNPSVHDEAREKMLTQK |
| Q9H8T0 | T22 | PSP | AKTIP FTS | NPFWSMSTSsVRKRSEGEEKtLTGDVKtsPPRTAPKKQLPS |
| Q9NP61 | S374 | Sugiyama | ARFGAP3 ARFGAP1 | SSYFDEPVELRsssFssWDDssDSyWKKETSKDTETVLKTT |
| Q9NP81 | S184 | Sugiyama | SARS2 SARSM | YLQALKLPNQTHPDVPVGDEsQARVLHMVGDKPVFSFQPRG |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NS15 | S871 | Sugiyama | LTBP3 | LCPQGHRLVGGRKCQDIDECsQDPSLCLPHGACKNLQGSYV |
| Q9NUU7 | T73 | Sugiyama | DDX19A DDX19L | EDRAAQsLLNKLIRSNLVDNtNQVEVLQRDPNsPLysVKsF |
| Q9NW75 | T235 | Sugiyama | GPATCH2 GPATC2 | KIIRQGPKIQDEGVVLESEEtNQTNKDKMECEEQKVSDELM |
| Q9NXG6 | S485 | Sugiyama | P4HTM PH4 | ARQALFQQEMARLAREGGtDsQPEWALDRAYRDARVEL___ |
| Q9NYF8 | S198 | Sugiyama | BCLAF1 BTF KIAA0164 | PLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGLsA |
| Q9NYF8 | S345 | Sugiyama | BCLAF1 BTF KIAA0164 | GGDQETAKtGKFLKRFtDEEsRVFLLDRGNtRDKEASKEKG |
| Q9NYF8 | T208 | Sugiyama | BCLAF1 BTF KIAA0164 | KDtFEHDPsEsIDEFNKssAtsGDIWPGLsAyDNsPRsPHs |
| Q9NZ53 | T603 | Sugiyama | PODXL2 UNQ1861/PRO3742 | WGALMGGKRDPEDsDVFEEDtHL__________________ |
| Q9P2E9 | T1120 | Sugiyama | RRBP1 KIAA1398 | PPAPAEPSSDLASKLREAEEtQstLQAECDQYRSILAETEG |
| Q9P2E9 | T1306 | Sugiyama | RRBP1 KIAA1398 | DPVQLKTQLEWTEAILEDEQtQRQKLTAEFEEAQTsACRLQ |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKI8 | S147 | Sugiyama | TLK1 KIAA0137 | AENQNEssQGKSIGGRGHKIsDyFEYQGGNGssPVRGIPPA |
| Q9UKI8 | S158 | Sugiyama | TLK1 KIAA0137 | SIGGRGHKIsDyFEYQGGNGssPVRGIPPAIRsPQNsHsHs |
| Q9UKI8 | S159 | Sugiyama | TLK1 KIAA0137 | IGGRGHKIsDyFEYQGGNGssPVRGIPPAIRsPQNsHsHst |
| Q9UKI8 | S226 | Sugiyama | TLK1 KIAA0137 | QLSFKIIQTDLTMLKLAALEsNKIQDLEKKEGRIDDLLRAN |
| Q9UKI8 | S54 | Sugiyama | TLK1 KIAA0137 | LLNHtPPsGRPREGAMDELHsLDPRRQELLEARFTGVAsGs |
| Q9UKI8 | S679 | Sugiyama | TLK1 KIAA0137 | SVGVIFFQCLYGRKPFGHNQsQQDILQENtILKATEVQFPV |
| Q9UKI8 | T688 | Sugiyama | TLK1 KIAA0137 | LYGRKPFGHNQsQQDILQENtILKATEVQFPVKPVVSSEAK |
| Q9UKV3 | S661 | Sugiyama | ACIN1 ACINUS KIAA0670 | SRSRSRSASSNSRKsLsPGVsRDsstsytEtKDPssGQEVA |
| Q9UKV3 | Y668 | Sugiyama | ACIN1 ACINUS KIAA0670 | ASSNSRKsLsPGVsRDsstsytEtKDPssGQEVAtPPVPQL |
| Q9UMR2 | T74 | Sugiyama | DDX19B DBP5 DDX19 TDBP | EDRAAQsLLNKLIRSNLVDNtNQVEVLQRDPNsPLysVKsF |
| Q9UMX5 | T76 | Sugiyama | NENF CIR2 SPUF | GGEEEDQPIyLAVKGVVFDVtSGKEFYGRGAPYNALTGKDS |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S2459 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | LLPPAQDQPRsPVPsAFsDQsRCLIAQTTPVAGSQSLSSGA |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T3 | S49 | Sugiyama | GDA KIAA1258 | LRDHLLGVSDSGKIVFLEEAsQQEKLAKEWCFKPCEIRELS |
| Q9Y2W1 | S217 | Sugiyama | THRAP3 BCLAF2 TRAP150 | QGDEAKEQtFsGGtsQDTKAsEssKPWPDAtyGtGsAsRAs |
| Q9Y2W1 | S234 | Sugiyama | THRAP3 BCLAF2 TRAP150 | TKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPALKsP |
| Q9Y2X3 | S434 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | AKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEI |
| Q9Y2X7 | T601 | Sugiyama | GIT1 | sRHtsKLsRHGsGADsDyENtQSGDPLLGLEGKRFLELGKE |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y450 | S65 | Sugiyama | HBS1L HBS1 KIAA1038 | RDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCL |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y4L1 | S742 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | KLQDLTLRDLEKQEREKAANsLEAFIFEtQDKLyQPEyQEV |
| Q9Y4L1 | T750 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | DLEKQEREKAANsLEAFIFEtQDKLyQPEyQEVsTEEQREE |
| Q9Y4X5 | S514 | Sugiyama | ARIH1 ARI MOP6 UBCH7BP HUSSY-27 | NQADLENATEVLSGYLERDIsQDsLQDIKQKVQDKYRYCES |
| Q9Y608 | S25 | Sugiyama | LRRFIP2 | ASGRKRTPVKDRFsAEDEALsNIAREAEARLAAKRAARAEA |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.177003e-11 | 10.662 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.259358e-07 | 6.646 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.279869e-06 | 5.642 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.305104e-06 | 5.637 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.667609e-06 | 5.331 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.082584e-05 | 4.966 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.076549e-05 | 4.968 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.575990e-05 | 4.802 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.545218e-05 | 4.594 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.678791e-05 | 4.572 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.692267e-05 | 4.433 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.838851e-05 | 4.234 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.070980e-05 | 4.217 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.065739e-04 | 3.972 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.756868e-04 | 3.755 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.783510e-04 | 3.749 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.783510e-04 | 3.749 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.301972e-04 | 3.638 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.153207e-04 | 3.667 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.474775e-04 | 3.606 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.913906e-04 | 3.536 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.963329e-04 | 3.402 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.910131e-04 | 3.408 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.196358e-04 | 3.377 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.755797e-04 | 3.425 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.944922e-04 | 3.226 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.638155e-04 | 3.178 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.616180e-04 | 3.179 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.067514e-04 | 3.151 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.701872e-04 | 3.113 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.828165e-04 | 3.106 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.268004e-04 | 3.033 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.449068e-04 | 3.025 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.173024e-03 | 2.931 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.162363e-03 | 2.935 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.557035e-03 | 2.808 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.557035e-03 | 2.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.557035e-03 | 2.808 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.557035e-03 | 2.808 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.526632e-03 | 2.816 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.349131e-03 | 2.870 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.648539e-03 | 2.783 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.904164e-03 | 2.720 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.950616e-03 | 2.710 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.808794e-03 | 2.743 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.800921e-03 | 2.745 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.055018e-03 | 2.687 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.055018e-03 | 2.687 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.102365e-03 | 2.677 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.055018e-03 | 2.687 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.159202e-03 | 2.666 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.238296e-03 | 2.650 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.308537e-03 | 2.637 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.883097e-03 | 2.540 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.883097e-03 | 2.540 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.213522e-03 | 2.493 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.184120e-03 | 2.497 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.462739e-03 | 2.461 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.675088e-03 | 2.435 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.675088e-03 | 2.435 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.599373e-03 | 2.444 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.250472e-03 | 2.372 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.415951e-03 | 2.355 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.550370e-03 | 2.342 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.234795e-03 | 2.281 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.613428e-03 | 2.251 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.473264e-03 | 2.262 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 6.438391e-03 | 2.191 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.414493e-03 | 2.130 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.414493e-03 | 2.130 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.379015e-03 | 2.132 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.932627e-03 | 2.159 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.622312e-03 | 2.179 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.338828e-03 | 2.134 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.629320e-03 | 2.179 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.248466e-03 | 2.140 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.942158e-03 | 2.159 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.788411e-03 | 2.109 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.376659e-03 | 2.077 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.376659e-03 | 2.077 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.522786e-03 | 2.069 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.522786e-03 | 2.069 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.134124e-03 | 2.090 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.655092e-03 | 2.063 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.938646e-03 | 2.049 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.938646e-03 | 2.049 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.000432e-02 | 2.000 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.000432e-02 | 2.000 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.252521e-03 | 2.034 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.849633e-03 | 2.007 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.566736e-03 | 2.019 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.696716e-03 | 2.013 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.009910e-02 | 1.996 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.057485e-02 | 1.976 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.131719e-02 | 1.946 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.157331e-02 | 1.937 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.270184e-02 | 1.896 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.388434e-02 | 1.857 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.421034e-02 | 1.847 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.421034e-02 | 1.847 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.370806e-02 | 1.863 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.445722e-02 | 1.840 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.470319e-02 | 1.833 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.470319e-02 | 1.833 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.470319e-02 | 1.833 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.584784e-02 | 1.800 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.615766e-02 | 1.792 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.615766e-02 | 1.792 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.548229e-02 | 1.810 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.581736e-02 | 1.801 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.585172e-02 | 1.800 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.663087e-02 | 1.779 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.663537e-02 | 1.779 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.663537e-02 | 1.779 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.710842e-02 | 1.767 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.904426e-02 | 1.720 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.904426e-02 | 1.720 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.873566e-02 | 1.727 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.873566e-02 | 1.727 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.983783e-02 | 1.703 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.818838e-02 | 1.740 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.873566e-02 | 1.727 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.866594e-02 | 1.729 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.827411e-02 | 1.738 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.983783e-02 | 1.703 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.818838e-02 | 1.740 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.904426e-02 | 1.720 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.269955e-02 | 1.644 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.346444e-02 | 1.630 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.346444e-02 | 1.630 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.269955e-02 | 1.644 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.269955e-02 | 1.644 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.346444e-02 | 1.630 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.101012e-02 | 1.678 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.346444e-02 | 1.630 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.346444e-02 | 1.630 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 2.140944e-02 | 1.669 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.146878e-02 | 1.668 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.346444e-02 | 1.630 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.304309e-02 | 1.637 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.149908e-02 | 1.668 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.282376e-02 | 1.642 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.442072e-02 | 1.612 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.455743e-02 | 1.610 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.506859e-02 | 1.601 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.524292e-02 | 1.598 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.610393e-02 | 1.583 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.610393e-02 | 1.583 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.670540e-02 | 1.573 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.670540e-02 | 1.573 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.734063e-02 | 1.563 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.768174e-02 | 1.558 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.893347e-02 | 1.539 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.893347e-02 | 1.539 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 3.226049e-02 | 1.491 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.092039e-02 | 1.510 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.035874e-02 | 1.518 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.035874e-02 | 1.518 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.035874e-02 | 1.518 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.035874e-02 | 1.518 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.195748e-02 | 1.495 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.156829e-02 | 1.501 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.365889e-02 | 1.473 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.365889e-02 | 1.473 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.500065e-02 | 1.456 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.500065e-02 | 1.456 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.517997e-02 | 1.454 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.517997e-02 | 1.454 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.591277e-02 | 1.445 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.591277e-02 | 1.445 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.839473e-02 | 1.416 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.860445e-02 | 1.413 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.112187e-02 | 1.386 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.112187e-02 | 1.386 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.112187e-02 | 1.386 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.223397e-02 | 1.374 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.223397e-02 | 1.374 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.480801e-02 | 1.349 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.480801e-02 | 1.349 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.449594e-02 | 1.352 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.607110e-02 | 1.337 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.838598e-02 | 1.315 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.480801e-02 | 1.349 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.607110e-02 | 1.337 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.692913e-02 | 1.329 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.607110e-02 | 1.337 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.975375e-02 | 1.303 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.841175e-02 | 1.315 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.607110e-02 | 1.337 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.011790e-02 | 1.300 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.011790e-02 | 1.300 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.258862e-02 | 1.279 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.293369e-02 | 1.276 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.293369e-02 | 1.276 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.293369e-02 | 1.276 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.348571e-02 | 1.272 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.437597e-02 | 1.265 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.437597e-02 | 1.265 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.437597e-02 | 1.265 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.536049e-02 | 1.257 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.626921e-02 | 1.250 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.883673e-02 | 1.230 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.883673e-02 | 1.230 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.883673e-02 | 1.230 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.883673e-02 | 1.230 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.130871e-02 | 1.212 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.133611e-02 | 1.212 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.133611e-02 | 1.212 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.133611e-02 | 1.212 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.135920e-02 | 1.212 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.414968e-02 | 1.130 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.414968e-02 | 1.130 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.071282e-02 | 1.151 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.978261e-02 | 1.156 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.002872e-02 | 1.155 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.423747e-02 | 1.192 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.071282e-02 | 1.151 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.319214e-02 | 1.136 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.448662e-02 | 1.191 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.414968e-02 | 1.130 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 7.414968e-02 | 1.130 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.669191e-02 | 1.176 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.598797e-02 | 1.181 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.106793e-02 | 1.148 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.414968e-02 | 1.130 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.319214e-02 | 1.136 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.071282e-02 | 1.151 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.598797e-02 | 1.181 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.563222e-02 | 1.183 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 7.414968e-02 | 1.130 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.414968e-02 | 1.130 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.598797e-02 | 1.181 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.601344e-02 | 1.119 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.704680e-02 | 1.113 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.712141e-02 | 1.113 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.885669e-02 | 1.103 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.933595e-02 | 1.101 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.069032e-02 | 1.093 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.077778e-02 | 1.093 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.165684e-02 | 1.088 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 9.056684e-02 | 1.043 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.056684e-02 | 1.043 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.023229e-01 | 0.990 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.500773e-02 | 1.022 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.438852e-02 | 1.074 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.022287e-01 | 0.990 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.932622e-02 | 1.049 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.932622e-02 | 1.049 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.023229e-01 | 0.990 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.056684e-02 | 1.043 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.424605e-02 | 1.074 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.252282e-02 | 1.083 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.457543e-02 | 1.024 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.225438e-02 | 1.035 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.020939e-01 | 0.991 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.056684e-02 | 1.043 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.334469e-02 | 1.079 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.708957e-02 | 1.013 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.607686e-02 | 1.017 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.173811e-02 | 1.037 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.999235e-02 | 1.000 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.056684e-02 | 1.043 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.588454e-02 | 1.066 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.056684e-02 | 1.043 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.173811e-02 | 1.037 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.123785e-02 | 1.040 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.820579e-02 | 1.055 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.820579e-02 | 1.055 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 9.705511e-02 | 1.013 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.054323e-01 | 0.977 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.054323e-01 | 0.977 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.054323e-01 | 0.977 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.054323e-01 | 0.977 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.054323e-01 | 0.977 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.054323e-01 | 0.977 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.054323e-01 | 0.977 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.055754e-01 | 0.976 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.057247e-01 | 0.976 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.079239e-01 | 0.967 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.079239e-01 | 0.967 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.079239e-01 | 0.967 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.079239e-01 | 0.967 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.079239e-01 | 0.967 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.079239e-01 | 0.967 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 1.139117e-01 | 0.943 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.139117e-01 | 0.943 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.139117e-01 | 0.943 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.141647e-01 | 0.942 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.147318e-01 | 0.940 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.159796e-01 | 0.936 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.168718e-01 | 0.932 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.170602e-01 | 0.932 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.171320e-01 | 0.931 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 1.539081e-01 | 0.813 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.539081e-01 | 0.813 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.539081e-01 | 0.813 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 1.539081e-01 | 0.813 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.539081e-01 | 0.813 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.539081e-01 | 0.813 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.260711e-01 | 0.899 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.260711e-01 | 0.899 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.448720e-01 | 0.839 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.448720e-01 | 0.839 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.513502e-01 | 0.820 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.359341e-01 | 0.867 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.507140e-01 | 0.822 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.424394e-01 | 0.846 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.491189e-01 | 0.826 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.233910e-01 | 0.909 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.233910e-01 | 0.909 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.436399e-01 | 0.843 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.248577e-01 | 0.904 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.295273e-01 | 0.888 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.225972e-01 | 0.912 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.282912e-01 | 0.892 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.384607e-01 | 0.859 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.436399e-01 | 0.843 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.448720e-01 | 0.839 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.295273e-01 | 0.888 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.539081e-01 | 0.813 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.260711e-01 | 0.899 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.513502e-01 | 0.820 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.513502e-01 | 0.820 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.384607e-01 | 0.859 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.248577e-01 | 0.904 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.233011e-01 | 0.909 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.539081e-01 | 0.813 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 1.260711e-01 | 0.899 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.452190e-01 | 0.838 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.506303e-01 | 0.822 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.448720e-01 | 0.839 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.448720e-01 | 0.839 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.329250e-01 | 0.876 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.581521e-01 | 0.801 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.282193e-01 | 0.892 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.537273e-01 | 0.813 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.448720e-01 | 0.839 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.186214e-01 | 0.926 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.491189e-01 | 0.826 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.362604e-01 | 0.866 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.312542e-01 | 0.882 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.384607e-01 | 0.859 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.513502e-01 | 0.820 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.583627e-01 | 0.800 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.583627e-01 | 0.800 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.997598e-01 | 0.699 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.997598e-01 | 0.699 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.431292e-01 | 0.614 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 2.431292e-01 | 0.614 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 2.431292e-01 | 0.614 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.431292e-01 | 0.614 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.431292e-01 | 0.614 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.431292e-01 | 0.614 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.431292e-01 | 0.614 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 2.431292e-01 | 0.614 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 2.841508e-01 | 0.546 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.841508e-01 | 0.546 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.841508e-01 | 0.546 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.841508e-01 | 0.546 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.642028e-01 | 0.785 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.642028e-01 | 0.785 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.839511e-01 | 0.735 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.839511e-01 | 0.735 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.839511e-01 | 0.735 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.229513e-01 | 0.491 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 3.229513e-01 | 0.491 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.040149e-01 | 0.690 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.040149e-01 | 0.690 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.040149e-01 | 0.690 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.243023e-01 | 0.649 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.243023e-01 | 0.649 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.243023e-01 | 0.649 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.243023e-01 | 0.649 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.243023e-01 | 0.649 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.243023e-01 | 0.649 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.243023e-01 | 0.649 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.243023e-01 | 0.649 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.596510e-01 | 0.444 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.596510e-01 | 0.444 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.596510e-01 | 0.444 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.646024e-01 | 0.784 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.781821e-01 | 0.749 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.943635e-01 | 0.404 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.943635e-01 | 0.404 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.943635e-01 | 0.404 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 3.943635e-01 | 0.404 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.943635e-01 | 0.404 | 0 | 0 |
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | R-HSA-3656244 | 3.943635e-01 | 0.404 | 0 | 0 |
| Defective CHST6 causes MCDC1 | R-HSA-3656225 | 3.943635e-01 | 0.404 | 0 | 0 |
| Defective ST3GAL3 causes MCT12 and EIEE15 | R-HSA-3656243 | 3.943635e-01 | 0.404 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.943635e-01 | 0.404 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.061857e-01 | 0.686 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.857166e-01 | 0.544 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.350919e-01 | 0.629 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.271962e-01 | 0.369 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.271962e-01 | 0.369 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.271962e-01 | 0.369 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.271962e-01 | 0.369 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.085664e-01 | 0.681 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.858035e-01 | 0.731 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.952790e-01 | 0.709 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.466194e-01 | 0.460 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.582509e-01 | 0.339 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.582509e-01 | 0.339 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.582509e-01 | 0.339 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.700087e-01 | 0.770 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.096797e-01 | 0.509 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.862790e-01 | 0.413 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.862790e-01 | 0.413 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.249919e-01 | 0.648 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.552226e-01 | 0.593 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.057145e-01 | 0.392 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.057145e-01 | 0.392 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.057145e-01 | 0.392 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.057145e-01 | 0.392 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.057145e-01 | 0.392 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.393651e-01 | 0.621 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.420664e-01 | 0.466 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.420664e-01 | 0.466 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.849019e-01 | 0.415 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.545657e-01 | 0.450 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.436557e-01 | 0.353 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.436557e-01 | 0.353 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.436557e-01 | 0.353 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.997728e-01 | 0.398 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.621160e-01 | 0.335 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.291137e-01 | 0.367 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.413572e-01 | 0.355 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.413572e-01 | 0.355 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 4.052550e-01 | 0.392 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.642535e-01 | 0.439 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.775772e-01 | 0.321 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.775772e-01 | 0.321 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.491216e-01 | 0.348 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.491216e-01 | 0.348 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.447302e-01 | 0.611 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.839511e-01 | 0.735 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.205422e-01 | 0.657 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.946116e-01 | 0.531 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.405057e-01 | 0.468 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.098470e-01 | 0.678 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.646461e-01 | 0.577 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.373672e-01 | 0.359 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.839379e-01 | 0.735 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.040149e-01 | 0.690 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.264648e-01 | 0.486 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.248482e-01 | 0.372 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.545657e-01 | 0.450 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.545657e-01 | 0.450 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.545657e-01 | 0.450 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.549262e-01 | 0.450 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 2.318375e-01 | 0.635 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.582509e-01 | 0.339 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.061857e-01 | 0.686 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.373672e-01 | 0.359 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.642028e-01 | 0.785 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.057145e-01 | 0.392 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.559011e-01 | 0.592 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.436557e-01 | 0.353 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.997728e-01 | 0.398 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.514497e-01 | 0.454 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.295793e-01 | 0.482 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.246084e-01 | 0.649 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.596510e-01 | 0.444 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.264648e-01 | 0.486 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.582509e-01 | 0.339 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.383882e-01 | 0.358 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.352622e-01 | 0.361 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.032348e-01 | 0.692 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.032348e-01 | 0.692 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.642923e-01 | 0.578 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.243023e-01 | 0.649 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.498032e-01 | 0.602 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.795915e-01 | 0.553 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.923286e-01 | 0.534 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.799418e-01 | 0.553 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.295793e-01 | 0.482 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.295793e-01 | 0.482 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.693662e-01 | 0.771 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.010225e-01 | 0.397 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.841508e-01 | 0.546 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.229513e-01 | 0.491 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 3.229513e-01 | 0.491 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.040149e-01 | 0.690 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.243023e-01 | 0.649 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.652240e-01 | 0.576 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 4.271962e-01 | 0.369 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.971948e-01 | 0.705 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.498032e-01 | 0.602 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.498032e-01 | 0.602 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.498032e-01 | 0.602 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.582509e-01 | 0.339 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.231918e-01 | 0.651 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.420664e-01 | 0.466 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.545657e-01 | 0.450 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.997728e-01 | 0.398 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.437099e-01 | 0.353 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.624882e-01 | 0.441 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.678162e-01 | 0.572 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.678162e-01 | 0.572 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.857166e-01 | 0.544 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.291137e-01 | 0.367 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.646461e-01 | 0.577 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.596510e-01 | 0.444 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 3.943635e-01 | 0.404 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 3.943635e-01 | 0.404 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.857166e-01 | 0.544 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.860213e-01 | 0.730 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.699468e-01 | 0.432 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.646461e-01 | 0.577 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.338616e-01 | 0.363 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.040149e-01 | 0.690 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.860213e-01 | 0.730 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.799418e-01 | 0.553 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.085664e-01 | 0.681 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.049184e-01 | 0.688 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.549262e-01 | 0.450 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 2.350919e-01 | 0.629 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.416512e-01 | 0.355 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.096531e-01 | 0.509 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.646024e-01 | 0.784 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.873018e-01 | 0.412 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.171178e-01 | 0.499 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.577707e-01 | 0.589 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.349880e-01 | 0.629 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.450540e-01 | 0.611 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 1.997598e-01 | 0.699 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.431292e-01 | 0.614 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.839511e-01 | 0.735 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.229513e-01 | 0.491 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.040149e-01 | 0.690 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.040149e-01 | 0.690 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.040149e-01 | 0.690 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.040149e-01 | 0.690 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.943635e-01 | 0.404 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.943635e-01 | 0.404 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.061480e-01 | 0.514 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.498032e-01 | 0.602 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.582509e-01 | 0.339 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.436557e-01 | 0.353 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.580798e-01 | 0.339 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.713731e-01 | 0.430 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.788555e-01 | 0.747 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.085664e-01 | 0.681 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.231918e-01 | 0.651 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.295793e-01 | 0.482 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.046961e-01 | 0.516 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.862790e-01 | 0.413 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.441304e-01 | 0.612 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.783381e-01 | 0.422 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.707855e-01 | 0.431 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.642028e-01 | 0.785 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.582509e-01 | 0.339 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.549262e-01 | 0.450 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.699468e-01 | 0.432 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.699468e-01 | 0.432 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.291926e-01 | 0.367 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.835668e-01 | 0.547 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.673831e-01 | 0.776 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.707855e-01 | 0.431 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.295232e-01 | 0.482 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.582509e-01 | 0.339 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.171178e-01 | 0.499 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.132317e-01 | 0.504 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.060720e-01 | 0.514 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.097217e-01 | 0.678 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.229513e-01 | 0.491 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.652240e-01 | 0.576 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.271962e-01 | 0.369 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.822768e-01 | 0.739 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.398604e-01 | 0.469 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.761386e-01 | 0.559 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.893945e-01 | 0.539 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.420664e-01 | 0.466 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.588448e-01 | 0.338 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.920546e-01 | 0.717 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.673831e-01 | 0.776 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.049184e-01 | 0.688 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.447302e-01 | 0.611 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.704203e-01 | 0.328 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.264648e-01 | 0.486 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.167871e-01 | 0.380 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.728435e-01 | 0.564 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.437099e-01 | 0.353 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.862901e-01 | 0.413 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.775772e-01 | 0.321 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.498032e-01 | 0.602 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.704203e-01 | 0.328 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.756670e-01 | 0.425 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.621160e-01 | 0.335 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.061857e-01 | 0.686 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.052550e-01 | 0.392 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.431292e-01 | 0.614 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.646461e-01 | 0.577 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.795915e-01 | 0.553 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.582509e-01 | 0.339 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.582509e-01 | 0.339 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.171178e-01 | 0.499 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.096797e-01 | 0.509 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.405677e-01 | 0.468 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.642028e-01 | 0.785 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.989661e-01 | 0.701 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.466194e-01 | 0.460 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.248482e-01 | 0.372 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.160368e-01 | 0.500 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.449145e-01 | 0.611 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.839511e-01 | 0.735 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.857166e-01 | 0.544 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.857166e-01 | 0.544 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.857166e-01 | 0.544 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.420664e-01 | 0.466 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.383882e-01 | 0.358 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.623481e-01 | 0.441 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.623481e-01 | 0.441 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.857166e-01 | 0.544 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.350919e-01 | 0.629 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.931926e-01 | 0.714 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.205422e-01 | 0.657 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.841508e-01 | 0.546 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.642028e-01 | 0.785 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.205422e-01 | 0.657 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.061480e-01 | 0.514 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.271962e-01 | 0.369 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.498032e-01 | 0.602 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.582509e-01 | 0.339 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.291926e-01 | 0.367 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.535216e-01 | 0.343 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.646461e-01 | 0.577 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.727588e-01 | 0.564 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.580798e-01 | 0.339 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.178039e-01 | 0.662 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.646024e-01 | 0.784 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.247706e-01 | 0.488 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.243023e-01 | 0.649 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.243023e-01 | 0.649 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.459528e-01 | 0.461 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 4.059337e-01 | 0.392 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.765873e-01 | 0.424 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.061857e-01 | 0.686 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.061857e-01 | 0.686 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.138597e-01 | 0.503 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.596510e-01 | 0.444 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.596510e-01 | 0.444 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.857166e-01 | 0.544 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.271962e-01 | 0.369 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.582509e-01 | 0.339 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.665698e-01 | 0.436 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.989125e-01 | 0.524 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.667916e-01 | 0.436 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.898965e-01 | 0.538 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.971948e-01 | 0.705 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.171178e-01 | 0.499 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.248449e-01 | 0.488 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.994805e-01 | 0.524 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.291926e-01 | 0.367 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.142258e-01 | 0.383 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.583585e-01 | 0.588 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.057145e-01 | 0.392 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.165445e-01 | 0.664 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.044282e-01 | 0.393 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.802118e-01 | 0.319 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.437099e-01 | 0.353 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.800302e-01 | 0.553 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.795915e-01 | 0.553 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.046961e-01 | 0.516 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 4.248482e-01 | 0.372 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.557021e-01 | 0.592 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.233246e-01 | 0.651 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.971109e-01 | 0.527 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 3.229513e-01 | 0.491 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.229513e-01 | 0.491 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.205422e-01 | 0.657 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.582509e-01 | 0.339 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.989661e-01 | 0.701 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.057145e-01 | 0.392 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.699468e-01 | 0.432 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.410614e-01 | 0.356 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.580798e-01 | 0.339 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.775772e-01 | 0.321 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.858035e-01 | 0.731 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.231867e-01 | 0.373 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.693662e-01 | 0.771 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.271962e-01 | 0.369 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.264648e-01 | 0.486 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.665698e-01 | 0.436 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.623481e-01 | 0.441 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.291926e-01 | 0.367 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.291926e-01 | 0.367 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.445849e-01 | 0.612 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.795915e-01 | 0.553 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.248482e-01 | 0.372 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.152538e-01 | 0.667 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.971948e-01 | 0.705 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.248482e-01 | 0.372 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.849019e-01 | 0.415 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.642028e-01 | 0.785 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.652240e-01 | 0.576 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.582509e-01 | 0.339 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.033144e-01 | 0.394 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.623481e-01 | 0.441 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.291137e-01 | 0.367 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.580798e-01 | 0.339 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.592845e-01 | 0.338 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.249919e-01 | 0.648 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.546448e-01 | 0.342 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.997728e-01 | 0.398 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.277896e-01 | 0.484 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.722892e-01 | 0.326 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.806779e-01 | 0.318 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.809729e-01 | 0.318 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.842296e-01 | 0.315 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.863265e-01 | 0.313 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.863265e-01 | 0.313 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.863265e-01 | 0.313 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.876238e-01 | 0.312 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.876238e-01 | 0.312 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.876238e-01 | 0.312 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.876238e-01 | 0.312 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.876238e-01 | 0.312 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.876238e-01 | 0.312 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.876238e-01 | 0.312 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.876238e-01 | 0.312 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.876238e-01 | 0.312 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.876238e-01 | 0.312 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.876238e-01 | 0.312 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.876238e-01 | 0.312 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.894515e-01 | 0.310 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.914530e-01 | 0.309 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.943486e-01 | 0.306 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.979281e-01 | 0.303 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.979281e-01 | 0.303 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.979281e-01 | 0.303 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.979281e-01 | 0.303 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.001807e-01 | 0.301 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.012134e-01 | 0.300 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.018550e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.018550e-01 | 0.299 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.023223e-01 | 0.299 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.026956e-01 | 0.299 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.107195e-01 | 0.292 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.116874e-01 | 0.291 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.128555e-01 | 0.290 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.128555e-01 | 0.290 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.138422e-01 | 0.289 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 5.138422e-01 | 0.289 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.152530e-01 | 0.288 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.152530e-01 | 0.288 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.152530e-01 | 0.288 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.152530e-01 | 0.288 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.152530e-01 | 0.288 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.152530e-01 | 0.288 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.154057e-01 | 0.288 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.154057e-01 | 0.288 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.154057e-01 | 0.288 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 5.154057e-01 | 0.288 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 5.154057e-01 | 0.288 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.154057e-01 | 0.288 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.154057e-01 | 0.288 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.154057e-01 | 0.288 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 5.154057e-01 | 0.288 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.154057e-01 | 0.288 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.154057e-01 | 0.288 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.174197e-01 | 0.286 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.190816e-01 | 0.285 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.224031e-01 | 0.282 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.224031e-01 | 0.282 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.243714e-01 | 0.280 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.243714e-01 | 0.280 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.243714e-01 | 0.280 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.243714e-01 | 0.280 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.243714e-01 | 0.280 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.243714e-01 | 0.280 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.273021e-01 | 0.278 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.273021e-01 | 0.278 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.273021e-01 | 0.278 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.273021e-01 | 0.278 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.321768e-01 | 0.274 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 5.321768e-01 | 0.274 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.357548e-01 | 0.271 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.357548e-01 | 0.271 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.364466e-01 | 0.270 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.416829e-01 | 0.266 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.416829e-01 | 0.266 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.416829e-01 | 0.266 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.416829e-01 | 0.266 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 5.416829e-01 | 0.266 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.416829e-01 | 0.266 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.416829e-01 | 0.266 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.416829e-01 | 0.266 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.416829e-01 | 0.266 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.416829e-01 | 0.266 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.470000e-01 | 0.262 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.470000e-01 | 0.262 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.486922e-01 | 0.261 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.486922e-01 | 0.261 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.486922e-01 | 0.261 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.486922e-01 | 0.261 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.486922e-01 | 0.261 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 5.486922e-01 | 0.261 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.537048e-01 | 0.257 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.574382e-01 | 0.254 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.619414e-01 | 0.250 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.623434e-01 | 0.250 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.647936e-01 | 0.248 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.647936e-01 | 0.248 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.647936e-01 | 0.248 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.647936e-01 | 0.248 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.647936e-01 | 0.248 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.647936e-01 | 0.248 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.647936e-01 | 0.248 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.647936e-01 | 0.248 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.663489e-01 | 0.247 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.663489e-01 | 0.247 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.663489e-01 | 0.247 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.665366e-01 | 0.247 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 5.665366e-01 | 0.247 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.665366e-01 | 0.247 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.665366e-01 | 0.247 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.665366e-01 | 0.247 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.665366e-01 | 0.247 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.665366e-01 | 0.247 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.690552e-01 | 0.245 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.690552e-01 | 0.245 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.751724e-01 | 0.240 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.772240e-01 | 0.239 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.789806e-01 | 0.237 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.789806e-01 | 0.237 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.798560e-01 | 0.237 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.804774e-01 | 0.236 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.804774e-01 | 0.236 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.804774e-01 | 0.236 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.804774e-01 | 0.236 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.804774e-01 | 0.236 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.804774e-01 | 0.236 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 5.805408e-01 | 0.236 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.900441e-01 | 0.229 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.900441e-01 | 0.229 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.900441e-01 | 0.229 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.900441e-01 | 0.229 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.900441e-01 | 0.229 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.900441e-01 | 0.229 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.900441e-01 | 0.229 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.900441e-01 | 0.229 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.900441e-01 | 0.229 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.900441e-01 | 0.229 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.900441e-01 | 0.229 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.900441e-01 | 0.229 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.900441e-01 | 0.229 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.900441e-01 | 0.229 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.900441e-01 | 0.229 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.911585e-01 | 0.228 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.913311e-01 | 0.228 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.913311e-01 | 0.228 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.914248e-01 | 0.228 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.943248e-01 | 0.226 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.943248e-01 | 0.226 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.943248e-01 | 0.226 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.957415e-01 | 0.225 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.957415e-01 | 0.225 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.009840e-01 | 0.221 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.100524e-01 | 0.215 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.100524e-01 | 0.215 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.105853e-01 | 0.214 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.105853e-01 | 0.214 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.105853e-01 | 0.214 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.105853e-01 | 0.214 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.105853e-01 | 0.214 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.113045e-01 | 0.214 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.122780e-01 | 0.213 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.122780e-01 | 0.213 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.122780e-01 | 0.213 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.122780e-01 | 0.213 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 6.122780e-01 | 0.213 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 6.122780e-01 | 0.213 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 6.122780e-01 | 0.213 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.122780e-01 | 0.213 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.122780e-01 | 0.213 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.122780e-01 | 0.213 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.122942e-01 | 0.213 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.153190e-01 | 0.211 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.188971e-01 | 0.208 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.191296e-01 | 0.208 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.215409e-01 | 0.207 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.250095e-01 | 0.204 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.250095e-01 | 0.204 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.259022e-01 | 0.203 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.261355e-01 | 0.203 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.269507e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.269507e-01 | 0.203 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.276736e-01 | 0.202 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.278917e-01 | 0.202 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.330202e-01 | 0.199 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.330202e-01 | 0.199 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.333073e-01 | 0.198 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.333073e-01 | 0.198 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.333073e-01 | 0.198 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.333073e-01 | 0.198 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.333073e-01 | 0.198 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.333073e-01 | 0.198 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.333073e-01 | 0.198 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 6.333073e-01 | 0.198 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.333073e-01 | 0.198 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.333073e-01 | 0.198 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.390159e-01 | 0.194 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.390159e-01 | 0.194 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.390159e-01 | 0.194 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.390159e-01 | 0.194 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.390159e-01 | 0.194 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.390159e-01 | 0.194 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.390159e-01 | 0.194 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.392541e-01 | 0.194 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 6.412586e-01 | 0.193 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.494795e-01 | 0.187 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.494795e-01 | 0.187 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.509004e-01 | 0.186 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.509004e-01 | 0.186 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.526074e-01 | 0.185 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.526074e-01 | 0.185 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.531972e-01 | 0.185 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.531972e-01 | 0.185 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.531972e-01 | 0.185 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.531972e-01 | 0.185 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.531972e-01 | 0.185 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.531972e-01 | 0.185 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.531972e-01 | 0.185 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.531972e-01 | 0.185 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.531972e-01 | 0.185 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.531972e-01 | 0.185 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.531972e-01 | 0.185 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.531972e-01 | 0.185 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.531972e-01 | 0.185 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.531972e-01 | 0.185 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.531972e-01 | 0.185 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.531972e-01 | 0.185 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.531972e-01 | 0.185 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.580716e-01 | 0.182 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.580716e-01 | 0.182 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.603744e-01 | 0.180 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.657855e-01 | 0.177 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.657878e-01 | 0.177 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.657878e-01 | 0.177 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.657878e-01 | 0.177 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.657878e-01 | 0.177 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.696604e-01 | 0.174 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.709143e-01 | 0.173 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.720095e-01 | 0.173 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.720095e-01 | 0.173 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.720095e-01 | 0.173 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.720095e-01 | 0.173 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.720095e-01 | 0.173 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.720095e-01 | 0.173 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.720095e-01 | 0.173 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.720095e-01 | 0.173 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.720095e-01 | 0.173 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.720095e-01 | 0.173 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.720095e-01 | 0.173 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.720095e-01 | 0.173 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.735478e-01 | 0.172 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.748240e-01 | 0.171 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.765611e-01 | 0.170 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.785618e-01 | 0.168 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.785618e-01 | 0.168 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.785618e-01 | 0.168 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.787764e-01 | 0.168 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.790847e-01 | 0.168 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.814229e-01 | 0.167 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.898023e-01 | 0.161 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 6.898023e-01 | 0.161 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.898023e-01 | 0.161 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.898023e-01 | 0.161 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.898023e-01 | 0.161 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.898023e-01 | 0.161 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.898023e-01 | 0.161 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.898023e-01 | 0.161 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.909345e-01 | 0.161 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.909345e-01 | 0.161 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.915772e-01 | 0.160 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.915772e-01 | 0.160 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.915772e-01 | 0.160 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.955271e-01 | 0.158 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.066309e-01 | 0.151 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.066309e-01 | 0.151 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.066309e-01 | 0.151 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.066309e-01 | 0.151 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.066309e-01 | 0.151 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.066309e-01 | 0.151 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.066309e-01 | 0.151 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.066309e-01 | 0.151 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.069655e-01 | 0.151 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.104831e-01 | 0.148 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.104831e-01 | 0.148 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 7.145005e-01 | 0.146 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.166432e-01 | 0.145 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.167185e-01 | 0.145 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.176343e-01 | 0.144 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.216990e-01 | 0.142 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.225475e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.225475e-01 | 0.141 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.225475e-01 | 0.141 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.225475e-01 | 0.141 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.225475e-01 | 0.141 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.230723e-01 | 0.141 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.257072e-01 | 0.139 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.257072e-01 | 0.139 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.257072e-01 | 0.139 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.297522e-01 | 0.137 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.297522e-01 | 0.137 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.365394e-01 | 0.133 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.365394e-01 | 0.133 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.365394e-01 | 0.133 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.365394e-01 | 0.133 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.365394e-01 | 0.133 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.365394e-01 | 0.133 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.365394e-01 | 0.133 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.365394e-01 | 0.133 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.376015e-01 | 0.132 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.376015e-01 | 0.132 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.376015e-01 | 0.132 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.376015e-01 | 0.132 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.376015e-01 | 0.132 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.376015e-01 | 0.132 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.376015e-01 | 0.132 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.376015e-01 | 0.132 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.376015e-01 | 0.132 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.451064e-01 | 0.128 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.453343e-01 | 0.128 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.470045e-01 | 0.127 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.473999e-01 | 0.126 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.473999e-01 | 0.126 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.475079e-01 | 0.126 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.518396e-01 | 0.124 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.518396e-01 | 0.124 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.518396e-01 | 0.124 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.518396e-01 | 0.124 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 7.518396e-01 | 0.124 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.518396e-01 | 0.124 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.518396e-01 | 0.124 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 7.518396e-01 | 0.124 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.534132e-01 | 0.123 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.558722e-01 | 0.122 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.571107e-01 | 0.121 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.571107e-01 | 0.121 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.571107e-01 | 0.121 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.571107e-01 | 0.121 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.571107e-01 | 0.121 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.642290e-01 | 0.117 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.644676e-01 | 0.117 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.653058e-01 | 0.116 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.653058e-01 | 0.116 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.653058e-01 | 0.116 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.653058e-01 | 0.116 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.653058e-01 | 0.116 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.653058e-01 | 0.116 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.653058e-01 | 0.116 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.653058e-01 | 0.116 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.666191e-01 | 0.115 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.666191e-01 | 0.115 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.668659e-01 | 0.115 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.668659e-01 | 0.115 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.703762e-01 | 0.113 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.703762e-01 | 0.113 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.703762e-01 | 0.113 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.721282e-01 | 0.112 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.738008e-01 | 0.111 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.758496e-01 | 0.110 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.780421e-01 | 0.109 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.780421e-01 | 0.109 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.780421e-01 | 0.109 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.780421e-01 | 0.109 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.853571e-01 | 0.105 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.900880e-01 | 0.102 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.900880e-01 | 0.102 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.900880e-01 | 0.102 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.900880e-01 | 0.102 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.900880e-01 | 0.102 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.900880e-01 | 0.102 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.900880e-01 | 0.102 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.900880e-01 | 0.102 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 7.900880e-01 | 0.102 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.900880e-01 | 0.102 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.908100e-01 | 0.102 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.908100e-01 | 0.102 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.908100e-01 | 0.102 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.948398e-01 | 0.100 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.948398e-01 | 0.100 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.013578e-01 | 0.096 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.014808e-01 | 0.096 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.014808e-01 | 0.096 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.014808e-01 | 0.096 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.014808e-01 | 0.096 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.014808e-01 | 0.096 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.014808e-01 | 0.096 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 8.014808e-01 | 0.096 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.025458e-01 | 0.096 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.025458e-01 | 0.096 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.025458e-01 | 0.096 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.089075e-01 | 0.092 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.106732e-01 | 0.091 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.122560e-01 | 0.090 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.122560e-01 | 0.090 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.122560e-01 | 0.090 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.122560e-01 | 0.090 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.122560e-01 | 0.090 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.122560e-01 | 0.090 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.156308e-01 | 0.089 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.156308e-01 | 0.089 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.185008e-01 | 0.087 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.189508e-01 | 0.087 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.201264e-01 | 0.086 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.224469e-01 | 0.085 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.224469e-01 | 0.085 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.224469e-01 | 0.085 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.260372e-01 | 0.083 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.260372e-01 | 0.083 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.260372e-01 | 0.083 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.260372e-01 | 0.083 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.260372e-01 | 0.083 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.266701e-01 | 0.083 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.284761e-01 | 0.082 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.297892e-01 | 0.081 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.302601e-01 | 0.081 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.320852e-01 | 0.080 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.320852e-01 | 0.080 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.320852e-01 | 0.080 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.320852e-01 | 0.080 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.320852e-01 | 0.080 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.341404e-01 | 0.079 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.405466e-01 | 0.075 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.409755e-01 | 0.075 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.412008e-01 | 0.075 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.412008e-01 | 0.075 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.412008e-01 | 0.075 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.412008e-01 | 0.075 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.412008e-01 | 0.075 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.412008e-01 | 0.075 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.412008e-01 | 0.075 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.412008e-01 | 0.075 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.412008e-01 | 0.075 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.412008e-01 | 0.075 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.412008e-01 | 0.075 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.463018e-01 | 0.072 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.469840e-01 | 0.072 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.469840e-01 | 0.072 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.469840e-01 | 0.072 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.498222e-01 | 0.071 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.498222e-01 | 0.071 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.498222e-01 | 0.071 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.518756e-01 | 0.070 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.534401e-01 | 0.069 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.534401e-01 | 0.069 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.545866e-01 | 0.068 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.552459e-01 | 0.068 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.552459e-01 | 0.068 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.572724e-01 | 0.067 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.579759e-01 | 0.067 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.579759e-01 | 0.067 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.579759e-01 | 0.067 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.579759e-01 | 0.067 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.579759e-01 | 0.067 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.584208e-01 | 0.066 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.589428e-01 | 0.066 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.596468e-01 | 0.066 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.596468e-01 | 0.066 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.622050e-01 | 0.064 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.624964e-01 | 0.064 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.653790e-01 | 0.063 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.656121e-01 | 0.063 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.656874e-01 | 0.063 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.656874e-01 | 0.063 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.656874e-01 | 0.063 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.656874e-01 | 0.063 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.656874e-01 | 0.063 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.656874e-01 | 0.063 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.656874e-01 | 0.063 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.675516e-01 | 0.062 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.692838e-01 | 0.061 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.704600e-01 | 0.060 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 8.713439e-01 | 0.060 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.729807e-01 | 0.059 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.729807e-01 | 0.059 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.768501e-01 | 0.057 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.772856e-01 | 0.057 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.798783e-01 | 0.056 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.864018e-01 | 0.052 | 0 | 0 |
| Keratan sulfate biosynthesis | R-HSA-2022854 | 8.864018e-01 | 0.052 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.864018e-01 | 0.052 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.864018e-01 | 0.052 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.864018e-01 | 0.052 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.872154e-01 | 0.052 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.872154e-01 | 0.052 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.872154e-01 | 0.052 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.883821e-01 | 0.051 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.904415e-01 | 0.050 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 8.914735e-01 | 0.050 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.925713e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.925713e-01 | 0.049 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.925713e-01 | 0.049 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.926813e-01 | 0.049 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.927539e-01 | 0.049 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.939473e-01 | 0.049 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.967670e-01 | 0.047 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 8.967670e-01 | 0.047 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.967670e-01 | 0.047 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.967670e-01 | 0.047 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.983585e-01 | 0.047 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.984062e-01 | 0.047 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.984062e-01 | 0.047 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.984062e-01 | 0.047 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.984062e-01 | 0.047 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.984062e-01 | 0.047 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.984062e-01 | 0.047 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.984062e-01 | 0.047 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.011448e-01 | 0.045 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.039244e-01 | 0.044 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.039244e-01 | 0.044 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.039244e-01 | 0.044 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.066345e-01 | 0.043 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.082522e-01 | 0.042 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.091433e-01 | 0.041 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.091433e-01 | 0.041 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.091433e-01 | 0.041 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.096906e-01 | 0.041 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.108149e-01 | 0.041 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.131892e-01 | 0.039 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.133291e-01 | 0.039 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.140790e-01 | 0.039 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.140790e-01 | 0.039 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.140790e-01 | 0.039 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.140790e-01 | 0.039 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.140790e-01 | 0.039 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.140790e-01 | 0.039 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.140790e-01 | 0.039 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.140990e-01 | 0.039 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.140990e-01 | 0.039 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.143793e-01 | 0.039 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.187468e-01 | 0.037 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.187468e-01 | 0.037 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.228733e-01 | 0.035 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.231613e-01 | 0.035 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.231613e-01 | 0.035 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.245745e-01 | 0.034 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.258666e-01 | 0.033 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.267034e-01 | 0.033 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.273362e-01 | 0.033 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.273362e-01 | 0.033 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.282064e-01 | 0.032 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.282064e-01 | 0.032 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.311186e-01 | 0.031 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.312845e-01 | 0.031 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.312845e-01 | 0.031 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.312845e-01 | 0.031 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.315593e-01 | 0.031 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.332389e-01 | 0.030 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.345576e-01 | 0.029 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.350185e-01 | 0.029 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.350185e-01 | 0.029 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.350185e-01 | 0.029 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.350185e-01 | 0.029 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.350185e-01 | 0.029 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.350185e-01 | 0.029 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.350185e-01 | 0.029 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.368399e-01 | 0.028 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.368399e-01 | 0.028 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.371231e-01 | 0.028 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.382202e-01 | 0.028 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.385498e-01 | 0.028 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.385498e-01 | 0.028 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.418894e-01 | 0.026 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.418894e-01 | 0.026 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.426289e-01 | 0.026 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.450477e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.452068e-01 | 0.024 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.462895e-01 | 0.024 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.462895e-01 | 0.024 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.480345e-01 | 0.023 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.480345e-01 | 0.023 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.480345e-01 | 0.023 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.480345e-01 | 0.023 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.480345e-01 | 0.023 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.480345e-01 | 0.023 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.484336e-01 | 0.023 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.508592e-01 | 0.022 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.519584e-01 | 0.021 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.522949e-01 | 0.021 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.522949e-01 | 0.021 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.529417e-01 | 0.021 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.535305e-01 | 0.021 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.535305e-01 | 0.021 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.540943e-01 | 0.020 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.552070e-01 | 0.020 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.559472e-01 | 0.020 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.559472e-01 | 0.020 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.560567e-01 | 0.020 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.560567e-01 | 0.020 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.560567e-01 | 0.020 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.584457e-01 | 0.018 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.599769e-01 | 0.018 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.607050e-01 | 0.017 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.622018e-01 | 0.017 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.625266e-01 | 0.017 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.628416e-01 | 0.016 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.628416e-01 | 0.016 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.628416e-01 | 0.016 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.628416e-01 | 0.016 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.629497e-01 | 0.016 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.639309e-01 | 0.016 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.646903e-01 | 0.016 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.648622e-01 | 0.016 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.674846e-01 | 0.014 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.683741e-01 | 0.014 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.686727e-01 | 0.014 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.701170e-01 | 0.013 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.702887e-01 | 0.013 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.714959e-01 | 0.013 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.719047e-01 | 0.012 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.719047e-01 | 0.012 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.730821e-01 | 0.012 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.735533e-01 | 0.012 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.743218e-01 | 0.011 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.746556e-01 | 0.011 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.748780e-01 | 0.011 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.748780e-01 | 0.011 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.752740e-01 | 0.011 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.752740e-01 | 0.011 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.762447e-01 | 0.010 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.764223e-01 | 0.010 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.775188e-01 | 0.010 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.775188e-01 | 0.010 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.775370e-01 | 0.010 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.785659e-01 | 0.009 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.787591e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.795658e-01 | 0.009 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.799148e-01 | 0.009 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.805203e-01 | 0.009 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.814316e-01 | 0.008 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.820294e-01 | 0.008 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.820412e-01 | 0.008 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.823014e-01 | 0.008 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.824011e-01 | 0.008 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.834198e-01 | 0.007 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.839376e-01 | 0.007 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.839427e-01 | 0.007 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.848166e-01 | 0.007 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.848166e-01 | 0.007 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.851838e-01 | 0.006 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.856430e-01 | 0.006 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.860901e-01 | 0.006 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.860901e-01 | 0.006 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.867167e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.870186e-01 | 0.006 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.873735e-01 | 0.006 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.873735e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.878623e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.878623e-01 | 0.005 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.878623e-01 | 0.005 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.878623e-01 | 0.005 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.883487e-01 | 0.005 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.885231e-01 | 0.005 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.885231e-01 | 0.005 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.891480e-01 | 0.005 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.900979e-01 | 0.004 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.905693e-01 | 0.004 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.911048e-01 | 0.004 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.913255e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.917980e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.917980e-01 | 0.004 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.917980e-01 | 0.004 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.918641e-01 | 0.004 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.926167e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.930666e-01 | 0.003 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.941315e-01 | 0.003 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.943608e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.953159e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.958125e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.960408e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.960523e-01 | 0.002 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.963041e-01 | 0.002 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.969827e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.970019e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.971197e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.972655e-01 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.973259e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.974717e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.977400e-01 | 0.001 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.977400e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.978632e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.983417e-01 | 0.001 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.984739e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.984992e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.986250e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.986402e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.987532e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.987884e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.988473e-01 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.988932e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.989102e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.989697e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.991094e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.991302e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.992244e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.992244e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.992950e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.993346e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.994748e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.995799e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.996423e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.997203e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997215e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.997324e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997493e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.998195e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998849e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999028e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999030e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999413e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999446e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999618e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999758e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999771e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999805e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999840e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999878e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999931e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999940e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999992e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999995e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999997e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999997e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.554312e-15 | 14.808 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.886580e-15 | 14.540 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.552714e-15 | 14.449 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.773160e-15 | 14.239 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.440093e-15 | 14.264 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.674039e-14 | 13.330 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.212364e-13 | 12.916 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.265166e-13 | 12.486 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.786171e-13 | 12.320 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.069900e-13 | 12.151 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.045231e-12 | 11.094 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.017497e-11 | 10.396 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.692613e-11 | 10.174 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.982170e-11 | 10.098 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.042825e-10 | 9.982 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.895373e-10 | 9.722 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.672030e-10 | 9.435 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.009395e-10 | 9.397 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.401383e-10 | 9.076 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.784772e-09 | 8.748 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.861372e-09 | 8.730 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.113299e-09 | 8.507 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.164434e-09 | 8.500 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.419626e-09 | 8.466 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.081284e-09 | 8.389 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.367102e-09 | 8.360 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.946783e-09 | 8.306 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.107480e-09 | 8.214 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.589711e-09 | 8.181 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.589711e-09 | 8.181 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.026829e-09 | 8.153 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.250257e-09 | 8.084 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.781394e-08 | 7.749 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.767312e-08 | 7.558 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.679289e-08 | 7.434 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.888431e-08 | 7.311 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.946939e-08 | 7.158 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.309888e-07 | 6.883 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.428224e-07 | 6.845 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.491212e-07 | 6.826 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.832374e-07 | 6.737 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.769531e-07 | 6.752 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.301266e-07 | 6.638 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.940917e-07 | 6.532 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.896850e-07 | 6.538 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.866349e-07 | 6.413 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.049584e-07 | 6.393 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.221086e-07 | 6.375 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.221086e-07 | 6.375 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.435923e-07 | 6.265 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.650636e-07 | 6.116 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.106166e-06 | 5.956 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.150981e-06 | 5.939 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.273159e-06 | 5.895 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.245872e-06 | 5.905 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.549391e-06 | 5.810 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.610893e-06 | 5.793 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.790258e-06 | 5.747 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.031500e-06 | 5.692 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.031500e-06 | 5.692 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.107452e-06 | 5.676 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.623192e-06 | 5.581 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.901551e-06 | 5.537 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.275354e-06 | 5.485 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.385118e-06 | 5.470 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.361981e-06 | 5.360 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.158791e-06 | 5.287 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.351206e-06 | 5.272 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.842948e-06 | 5.233 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.883093e-06 | 5.230 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.148274e-06 | 5.146 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.868349e-06 | 5.163 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.186141e-06 | 5.144 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.186141e-06 | 5.144 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.427959e-06 | 5.026 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.612174e-06 | 5.017 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.101088e-05 | 4.958 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.141653e-05 | 4.942 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.201274e-05 | 4.920 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.417683e-05 | 4.848 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.432260e-05 | 4.844 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.489802e-05 | 4.827 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.579033e-05 | 4.802 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.579033e-05 | 4.802 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.777747e-05 | 4.750 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.852476e-05 | 4.732 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.022948e-05 | 4.694 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.127848e-05 | 4.672 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.238144e-05 | 4.650 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.016776e-05 | 4.520 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.129914e-05 | 4.504 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.583472e-05 | 4.446 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.521286e-05 | 4.453 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.518859e-05 | 4.454 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.761092e-05 | 4.425 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.793854e-05 | 4.421 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.847893e-05 | 4.415 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.852287e-05 | 4.414 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.905426e-05 | 4.408 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.987181e-05 | 4.399 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.305167e-05 | 4.366 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.546592e-05 | 4.342 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.606929e-05 | 4.337 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.890409e-05 | 4.311 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.900144e-05 | 4.310 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.944064e-05 | 4.306 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.132941e-05 | 4.290 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.860632e-05 | 4.232 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.887474e-05 | 4.230 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.375985e-05 | 4.195 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.493875e-05 | 4.187 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.294766e-05 | 4.137 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.418289e-05 | 4.130 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.322403e-05 | 4.080 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.835380e-05 | 4.054 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.256511e-05 | 4.083 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.164734e-05 | 4.038 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.495598e-05 | 4.022 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.920051e-05 | 4.003 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.920051e-05 | 4.003 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.920051e-05 | 4.003 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.920051e-05 | 4.003 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.920051e-05 | 4.003 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.101625e-04 | 3.958 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.041676e-04 | 3.982 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.036745e-04 | 3.984 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.101625e-04 | 3.958 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.126482e-04 | 3.948 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.126482e-04 | 3.948 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.216802e-04 | 3.915 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.232304e-04 | 3.909 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.241017e-04 | 3.906 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.323048e-04 | 3.878 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.419902e-04 | 3.848 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.487102e-04 | 3.828 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.491864e-04 | 3.826 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.419214e-04 | 3.848 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.480837e-04 | 3.829 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.573928e-04 | 3.803 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.598619e-04 | 3.796 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.628597e-04 | 3.788 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.628597e-04 | 3.788 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.630217e-04 | 3.788 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.754543e-04 | 3.756 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.921013e-04 | 3.716 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.982849e-04 | 3.703 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.111854e-04 | 3.675 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.146721e-04 | 3.668 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.111854e-04 | 3.675 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.207380e-04 | 3.656 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.335554e-04 | 3.632 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.487682e-04 | 3.604 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.492623e-04 | 3.603 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.678619e-04 | 3.572 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.761831e-04 | 3.559 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.935009e-04 | 3.532 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.990049e-04 | 3.524 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.088991e-04 | 3.510 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.159060e-04 | 3.500 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.160514e-04 | 3.500 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.534199e-04 | 3.452 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.537880e-04 | 3.451 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.683358e-04 | 3.434 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.546001e-04 | 3.450 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.534199e-04 | 3.452 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.390336e-04 | 3.470 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.990087e-04 | 3.399 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.066212e-04 | 3.391 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.326161e-04 | 3.364 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.355299e-04 | 3.361 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.397851e-04 | 3.357 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.542861e-04 | 3.343 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.775114e-04 | 3.321 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.796355e-04 | 3.319 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.964128e-04 | 3.304 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.079796e-04 | 3.294 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.172420e-04 | 3.286 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.671502e-04 | 3.246 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.687889e-04 | 3.245 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.829619e-04 | 3.234 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.906576e-04 | 3.229 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.969985e-04 | 3.224 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.747599e-04 | 3.171 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.126412e-04 | 3.213 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.040103e-04 | 3.219 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.534021e-04 | 3.185 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.847314e-04 | 3.164 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.890719e-04 | 3.162 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.452384e-04 | 3.128 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.712245e-04 | 3.113 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.972018e-04 | 3.098 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.134976e-04 | 3.090 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.142450e-04 | 3.089 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.240724e-04 | 3.084 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.240724e-04 | 3.084 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.244278e-04 | 3.084 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.632657e-04 | 3.016 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.632657e-04 | 3.016 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.632657e-04 | 3.016 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.632657e-04 | 3.016 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.016899e-03 | 2.993 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.014673e-03 | 2.994 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.376160e-04 | 3.028 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.875387e-04 | 3.005 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.792922e-04 | 3.009 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.077449e-03 | 2.968 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.077449e-03 | 2.968 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.085911e-03 | 2.964 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.096858e-03 | 2.960 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.099734e-03 | 2.959 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.099734e-03 | 2.959 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.143954e-03 | 2.942 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.143954e-03 | 2.942 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.143954e-03 | 2.942 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.154110e-03 | 2.938 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.197318e-03 | 2.922 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.197318e-03 | 2.922 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.248288e-03 | 2.904 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.249840e-03 | 2.903 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.288829e-03 | 2.890 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.288829e-03 | 2.890 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.288829e-03 | 2.890 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.313568e-03 | 2.882 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.373917e-03 | 2.862 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.426583e-03 | 2.846 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.475925e-03 | 2.831 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.475925e-03 | 2.831 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.480771e-03 | 2.830 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.500742e-03 | 2.824 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.616210e-03 | 2.792 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.685596e-03 | 2.773 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.753667e-03 | 2.756 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.867463e-03 | 2.729 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.733118e-03 | 2.761 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.818441e-03 | 2.740 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.887262e-03 | 2.724 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.923515e-03 | 2.716 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.943841e-03 | 2.711 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.943841e-03 | 2.711 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.982643e-03 | 2.703 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.005006e-03 | 2.698 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.021666e-03 | 2.694 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.021666e-03 | 2.694 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.070132e-03 | 2.684 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.121916e-03 | 2.673 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.126950e-03 | 2.672 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.127553e-03 | 2.672 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.187531e-03 | 2.660 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.187531e-03 | 2.660 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.194180e-03 | 2.659 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.216997e-03 | 2.654 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.239663e-03 | 2.650 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.239663e-03 | 2.650 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.355009e-03 | 2.628 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.387535e-03 | 2.622 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.387535e-03 | 2.622 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.397750e-03 | 2.620 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.440069e-03 | 2.613 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.440069e-03 | 2.613 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.440069e-03 | 2.613 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.521272e-03 | 2.598 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.584952e-03 | 2.588 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.648070e-03 | 2.577 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.648070e-03 | 2.577 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.656420e-03 | 2.576 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.006303e-03 | 2.522 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.967077e-03 | 2.528 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.967077e-03 | 2.528 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.806324e-03 | 2.552 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.792114e-03 | 2.554 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.150134e-03 | 2.502 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.031458e-03 | 2.518 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.048655e-03 | 2.516 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.832688e-03 | 2.548 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.832032e-03 | 2.548 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.735655e-03 | 2.563 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.967077e-03 | 2.528 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.076588e-03 | 2.512 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.238486e-03 | 2.490 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.967077e-03 | 2.528 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.238486e-03 | 2.490 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.274527e-03 | 2.485 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.292850e-03 | 2.482 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.408968e-03 | 2.467 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.525387e-03 | 2.453 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.525387e-03 | 2.453 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.544751e-03 | 2.450 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.558314e-03 | 2.449 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.610433e-03 | 2.442 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.610433e-03 | 2.442 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.741858e-03 | 2.427 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.804208e-03 | 2.420 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.847084e-03 | 2.415 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.935296e-03 | 2.405 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.006761e-03 | 2.397 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.135099e-03 | 2.384 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.295356e-03 | 2.367 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.307474e-03 | 2.366 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.333985e-03 | 2.363 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.344195e-03 | 2.362 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.480360e-03 | 2.349 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.484626e-03 | 2.348 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.484626e-03 | 2.348 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.583690e-03 | 2.339 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.671993e-03 | 2.330 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.686965e-03 | 2.329 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.705876e-03 | 2.327 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.705876e-03 | 2.327 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.714769e-03 | 2.327 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.714769e-03 | 2.327 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.826816e-03 | 2.316 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.050078e-03 | 2.297 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.225444e-03 | 2.282 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.250427e-03 | 2.280 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.360121e-03 | 2.271 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.488501e-03 | 2.261 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.647636e-03 | 2.248 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.694949e-03 | 2.245 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.851529e-03 | 2.233 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.854380e-03 | 2.233 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.899352e-03 | 2.229 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.899352e-03 | 2.229 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.949177e-03 | 2.226 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.952101e-03 | 2.225 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.906540e-03 | 2.161 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.906540e-03 | 2.161 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.161963e-03 | 2.210 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.161963e-03 | 2.210 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.726756e-03 | 2.172 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.036664e-03 | 2.153 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.762938e-03 | 2.170 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.762938e-03 | 2.170 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.121101e-03 | 2.213 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.726756e-03 | 2.172 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.410255e-03 | 2.193 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.217551e-03 | 2.206 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.852369e-03 | 2.164 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.456588e-03 | 2.190 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.164989e-03 | 2.210 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.193721e-03 | 2.208 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.906540e-03 | 2.161 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.613448e-03 | 2.118 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.984186e-03 | 2.156 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.731231e-03 | 2.112 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.922459e-03 | 2.101 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.929893e-03 | 2.101 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.094262e-03 | 2.092 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.168614e-03 | 2.088 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.521760e-03 | 2.069 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.992355e-03 | 2.046 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.188247e-03 | 2.037 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.331382e-03 | 2.030 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.797457e-03 | 2.009 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.797457e-03 | 2.009 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 9.797457e-03 | 2.009 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.834070e-03 | 2.007 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 9.971262e-03 | 2.001 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.001736e-02 | 1.999 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.004570e-02 | 1.998 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.013027e-02 | 1.994 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.020326e-02 | 1.991 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.020326e-02 | 1.991 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.031568e-02 | 1.987 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.044349e-02 | 1.981 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.047134e-02 | 1.980 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.063297e-02 | 1.973 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.077352e-02 | 1.968 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.106552e-02 | 1.956 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.106552e-02 | 1.956 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.106552e-02 | 1.956 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.123012e-02 | 1.950 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.125663e-02 | 1.949 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.168523e-02 | 1.932 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.212686e-02 | 1.916 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.254632e-02 | 1.901 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.270113e-02 | 1.896 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.274068e-02 | 1.895 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.314745e-02 | 1.881 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.319783e-02 | 1.879 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.334944e-02 | 1.875 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.342613e-02 | 1.872 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.342613e-02 | 1.872 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.362799e-02 | 1.866 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.365822e-02 | 1.865 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.369467e-02 | 1.863 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.377972e-02 | 1.861 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.377972e-02 | 1.861 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.377972e-02 | 1.861 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.380475e-02 | 1.860 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.391637e-02 | 1.856 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.391637e-02 | 1.856 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.451272e-02 | 1.838 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.452475e-02 | 1.838 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.452475e-02 | 1.838 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.452475e-02 | 1.838 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.519018e-02 | 1.818 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.534016e-02 | 1.814 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.534016e-02 | 1.814 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.538302e-02 | 1.813 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.546568e-02 | 1.811 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.553549e-02 | 1.809 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.599608e-02 | 1.796 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.628925e-02 | 1.788 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.632946e-02 | 1.787 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.709978e-02 | 1.767 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.709978e-02 | 1.767 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.709978e-02 | 1.767 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.709978e-02 | 1.767 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.755044e-02 | 1.756 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.760504e-02 | 1.754 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.774385e-02 | 1.751 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.784031e-02 | 1.749 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 1.786571e-02 | 1.748 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.786571e-02 | 1.748 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.846639e-02 | 1.734 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.957076e-02 | 1.708 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.132832e-02 | 1.671 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 1.883751e-02 | 1.725 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.883751e-02 | 1.725 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.913333e-02 | 1.718 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.193799e-02 | 1.659 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.935709e-02 | 1.713 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.428104e-02 | 1.615 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.281585e-02 | 1.642 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.120604e-02 | 1.674 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.221553e-02 | 1.653 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.265333e-02 | 1.645 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.168799e-02 | 1.664 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.291438e-02 | 1.640 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.123005e-02 | 1.673 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.501275e-02 | 1.602 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.102175e-02 | 1.677 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.132832e-02 | 1.671 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.534597e-02 | 1.596 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.557990e-02 | 1.592 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.563787e-02 | 1.591 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.619117e-02 | 1.582 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.621212e-02 | 1.581 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.621212e-02 | 1.581 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.621212e-02 | 1.581 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.641372e-02 | 1.578 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.652572e-02 | 1.576 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.668791e-02 | 1.574 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.668791e-02 | 1.574 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.687670e-02 | 1.571 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.687670e-02 | 1.571 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.687670e-02 | 1.571 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.706175e-02 | 1.568 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.706175e-02 | 1.568 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.706175e-02 | 1.568 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.755253e-02 | 1.560 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.755253e-02 | 1.560 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.755253e-02 | 1.560 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.781904e-02 | 1.556 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.877090e-02 | 1.541 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.877090e-02 | 1.541 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.941965e-02 | 1.531 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.941965e-02 | 1.531 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.941965e-02 | 1.531 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.945866e-02 | 1.531 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.945866e-02 | 1.531 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.945866e-02 | 1.531 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.096034e-02 | 1.509 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.096034e-02 | 1.509 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.096034e-02 | 1.509 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.099402e-02 | 1.509 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.118735e-02 | 1.506 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.118735e-02 | 1.506 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.118735e-02 | 1.506 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.178598e-02 | 1.498 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.178598e-02 | 1.498 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.224335e-02 | 1.492 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.266302e-02 | 1.486 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.274910e-02 | 1.485 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.285711e-02 | 1.483 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.357010e-02 | 1.474 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.408465e-02 | 1.467 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.514725e-02 | 1.454 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.581127e-02 | 1.446 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.636160e-02 | 1.439 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.743833e-02 | 1.427 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.801723e-02 | 1.420 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.807894e-02 | 1.419 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.807894e-02 | 1.419 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.807894e-02 | 1.419 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.807894e-02 | 1.419 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.807894e-02 | 1.419 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.811052e-02 | 1.419 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.811052e-02 | 1.419 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.811052e-02 | 1.419 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.944123e-02 | 1.404 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.944410e-02 | 1.404 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.944410e-02 | 1.404 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.944410e-02 | 1.404 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.944410e-02 | 1.404 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.953255e-02 | 1.403 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.953255e-02 | 1.403 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.043977e-02 | 1.393 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.043977e-02 | 1.393 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.065886e-02 | 1.391 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.098172e-02 | 1.387 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.098172e-02 | 1.387 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.098172e-02 | 1.387 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.109460e-02 | 1.386 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.359824e-02 | 1.361 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.389141e-02 | 1.358 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.408874e-02 | 1.356 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.418192e-02 | 1.355 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.439514e-02 | 1.353 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.439514e-02 | 1.353 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.439514e-02 | 1.353 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.482895e-02 | 1.348 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.482895e-02 | 1.348 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.482895e-02 | 1.348 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.482895e-02 | 1.348 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.511394e-02 | 1.346 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.511394e-02 | 1.346 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.527778e-02 | 1.344 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.669459e-02 | 1.331 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.730086e-02 | 1.325 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.823410e-02 | 1.317 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.857470e-02 | 1.314 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.909088e-02 | 1.309 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 6.822409e-02 | 1.166 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.468562e-02 | 1.262 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.468562e-02 | 1.262 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.379264e-02 | 1.195 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.404262e-02 | 1.267 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.404262e-02 | 1.267 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.404262e-02 | 1.267 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.404262e-02 | 1.267 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.404262e-02 | 1.267 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.427208e-02 | 1.192 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.427208e-02 | 1.192 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.427208e-02 | 1.192 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.526516e-02 | 1.185 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.684645e-02 | 1.175 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.445903e-02 | 1.264 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.020043e-02 | 1.220 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.282516e-02 | 1.138 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.032355e-02 | 1.298 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.146985e-02 | 1.211 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.445903e-02 | 1.264 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.961869e-02 | 1.225 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.739218e-02 | 1.241 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.070939e-02 | 1.295 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.058976e-02 | 1.296 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.404262e-02 | 1.267 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.404262e-02 | 1.267 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.739218e-02 | 1.241 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.138827e-02 | 1.289 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.404262e-02 | 1.267 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.744590e-02 | 1.171 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.182820e-02 | 1.285 | 0 | 0 |
| Translation | R-HSA-72766 | 6.101875e-02 | 1.215 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.256866e-02 | 1.279 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.013602e-02 | 1.300 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.655509e-02 | 1.177 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.443277e-02 | 1.264 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.322523e-02 | 1.274 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 6.822409e-02 | 1.166 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.375896e-02 | 1.132 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.888135e-02 | 1.162 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.739218e-02 | 1.241 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.020043e-02 | 1.220 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.020043e-02 | 1.220 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.164636e-02 | 1.210 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.080461e-02 | 1.150 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.219056e-02 | 1.142 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.379264e-02 | 1.195 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.684645e-02 | 1.175 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.080461e-02 | 1.150 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 6.526516e-02 | 1.185 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.468562e-02 | 1.262 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.411818e-02 | 1.130 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.411818e-02 | 1.130 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.411818e-02 | 1.130 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.411818e-02 | 1.130 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.459128e-02 | 1.127 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.459128e-02 | 1.127 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.459128e-02 | 1.127 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.459128e-02 | 1.127 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.551036e-02 | 1.122 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.551036e-02 | 1.122 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.598194e-02 | 1.119 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.603494e-02 | 1.119 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.761662e-02 | 1.110 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.762434e-02 | 1.110 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.971611e-02 | 1.098 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.086169e-02 | 1.092 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.090923e-02 | 1.092 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.164748e-02 | 1.088 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.164748e-02 | 1.088 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.164748e-02 | 1.088 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.164748e-02 | 1.088 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.285480e-02 | 1.082 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.285480e-02 | 1.082 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.287361e-02 | 1.082 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.287361e-02 | 1.082 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.287361e-02 | 1.082 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.287361e-02 | 1.082 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.357633e-02 | 1.078 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.357633e-02 | 1.078 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.485830e-02 | 1.071 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.773988e-02 | 1.057 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.773988e-02 | 1.057 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.773988e-02 | 1.057 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.773988e-02 | 1.057 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.773988e-02 | 1.057 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.962135e-02 | 1.048 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.977268e-02 | 1.047 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.104055e-02 | 1.041 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.163591e-02 | 1.038 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.163591e-02 | 1.038 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.163591e-02 | 1.038 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.166396e-02 | 1.038 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.177506e-02 | 1.037 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.177506e-02 | 1.037 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.185712e-02 | 1.037 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.185712e-02 | 1.037 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.260526e-02 | 1.033 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.260526e-02 | 1.033 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 9.280406e-02 | 1.032 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.280406e-02 | 1.032 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.280406e-02 | 1.032 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.280406e-02 | 1.032 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.280406e-02 | 1.032 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.961337e-02 | 1.002 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.961337e-02 | 1.002 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.961337e-02 | 1.002 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.961337e-02 | 1.002 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 9.961337e-02 | 1.002 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 9.961337e-02 | 1.002 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.961337e-02 | 1.002 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.006946e-01 | 0.997 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.006946e-01 | 0.997 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.006946e-01 | 0.997 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.006946e-01 | 0.997 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.006946e-01 | 0.997 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.006946e-01 | 0.997 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.006946e-01 | 0.997 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.006946e-01 | 0.997 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.006946e-01 | 0.997 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.006946e-01 | 0.997 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.006946e-01 | 0.997 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.006946e-01 | 0.997 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.006946e-01 | 0.997 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.006946e-01 | 0.997 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.006946e-01 | 0.997 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.006946e-01 | 0.997 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.006946e-01 | 0.997 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.006946e-01 | 0.997 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.006946e-01 | 0.997 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.006946e-01 | 0.997 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.006946e-01 | 0.997 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.006946e-01 | 0.997 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.006946e-01 | 0.997 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.006946e-01 | 0.997 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.006946e-01 | 0.997 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.009309e-01 | 0.996 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.009309e-01 | 0.996 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.009309e-01 | 0.996 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.009333e-01 | 0.996 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.009333e-01 | 0.996 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.027187e-01 | 0.988 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.029463e-01 | 0.987 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.029463e-01 | 0.987 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.029463e-01 | 0.987 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.033877e-01 | 0.986 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.033877e-01 | 0.986 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.068956e-01 | 0.971 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.068956e-01 | 0.971 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.092820e-01 | 0.961 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.107335e-01 | 0.956 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.118625e-01 | 0.951 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.120046e-01 | 0.951 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.127105e-01 | 0.948 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.134656e-01 | 0.945 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.134656e-01 | 0.945 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.138853e-01 | 0.944 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.160506e-01 | 0.935 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.161875e-01 | 0.935 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.185387e-01 | 0.926 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.185794e-01 | 0.926 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.199790e-01 | 0.921 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.219524e-01 | 0.914 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.225528e-01 | 0.912 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.912551e-01 | 0.718 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.912551e-01 | 0.718 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.912551e-01 | 0.718 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.912551e-01 | 0.718 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.912551e-01 | 0.718 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.912551e-01 | 0.718 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.912551e-01 | 0.718 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 1.341305e-01 | 0.872 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.341305e-01 | 0.872 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.341305e-01 | 0.872 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.341305e-01 | 0.872 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.341305e-01 | 0.872 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.708282e-01 | 0.767 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.708282e-01 | 0.767 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.708282e-01 | 0.767 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.708282e-01 | 0.767 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.367792e-01 | 0.864 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.367792e-01 | 0.864 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.089179e-01 | 0.680 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.089179e-01 | 0.680 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.089179e-01 | 0.680 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.615535e-01 | 0.792 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.615535e-01 | 0.792 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.477478e-01 | 0.606 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.477478e-01 | 0.606 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.655425e-01 | 0.781 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.655425e-01 | 0.781 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.145115e-01 | 0.669 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.145115e-01 | 0.669 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.145115e-01 | 0.669 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.145115e-01 | 0.669 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.458972e-01 | 0.836 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.862232e-01 | 0.730 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.625117e-01 | 0.789 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.424828e-01 | 0.846 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.424828e-01 | 0.846 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.424828e-01 | 0.846 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.798418e-01 | 0.745 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.798418e-01 | 0.745 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.568360e-01 | 0.805 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.568360e-01 | 0.805 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.978227e-01 | 0.704 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.318235e-01 | 0.880 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.769265e-01 | 0.752 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.387377e-01 | 0.858 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.688664e-01 | 0.772 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.205381e-01 | 0.657 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.358592e-01 | 0.627 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.358592e-01 | 0.627 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.358592e-01 | 0.627 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.358592e-01 | 0.627 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.685967e-01 | 0.773 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.896898e-01 | 0.722 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.157584e-01 | 0.666 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.331620e-01 | 0.876 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.458972e-01 | 0.836 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.717912e-01 | 0.765 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.430863e-01 | 0.844 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.873082e-01 | 0.727 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.254077e-01 | 0.902 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.235602e-01 | 0.651 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.163872e-01 | 0.665 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.769265e-01 | 0.752 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.058944e-01 | 0.686 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 1.708282e-01 | 0.767 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.615535e-01 | 0.792 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.477478e-01 | 0.606 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.477478e-01 | 0.606 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.625117e-01 | 0.789 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.798418e-01 | 0.745 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.501273e-01 | 0.824 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.330878e-01 | 0.876 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.121992e-01 | 0.673 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.501273e-01 | 0.824 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.318235e-01 | 0.880 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.477478e-01 | 0.606 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.862232e-01 | 0.730 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.882909e-01 | 0.725 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.311048e-01 | 0.636 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.548073e-01 | 0.810 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.287687e-01 | 0.890 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.311048e-01 | 0.636 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.865634e-01 | 0.729 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.163872e-01 | 0.665 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.163872e-01 | 0.665 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.912551e-01 | 0.718 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.424828e-01 | 0.846 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.254077e-01 | 0.902 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.300593e-01 | 0.886 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.569458e-01 | 0.804 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.089179e-01 | 0.680 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.269640e-01 | 0.896 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.625117e-01 | 0.789 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.572969e-01 | 0.803 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.469786e-01 | 0.607 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.486609e-01 | 0.828 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.477478e-01 | 0.606 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.477478e-01 | 0.606 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.367925e-01 | 0.626 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.457526e-01 | 0.836 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.094401e-01 | 0.679 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.497080e-01 | 0.825 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.318987e-01 | 0.635 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.315956e-01 | 0.635 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.795517e-01 | 0.746 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.912551e-01 | 0.718 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.912551e-01 | 0.718 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.912551e-01 | 0.718 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.341305e-01 | 0.872 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.367792e-01 | 0.864 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.875438e-01 | 0.727 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.145115e-01 | 0.669 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.422274e-01 | 0.616 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.297995e-01 | 0.639 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.501273e-01 | 0.824 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.501273e-01 | 0.824 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.358592e-01 | 0.627 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.358592e-01 | 0.627 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.479882e-01 | 0.830 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.430863e-01 | 0.844 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.058944e-01 | 0.686 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.254077e-01 | 0.902 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.325095e-01 | 0.878 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.862232e-01 | 0.730 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.152149e-01 | 0.667 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.367792e-01 | 0.864 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.367925e-01 | 0.626 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.390721e-01 | 0.857 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.336488e-01 | 0.631 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.089179e-01 | 0.680 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.055869e-01 | 0.687 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.452592e-01 | 0.838 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.089953e-01 | 0.680 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.940104e-01 | 0.712 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.300593e-01 | 0.886 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.910390e-01 | 0.719 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.439518e-01 | 0.613 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.198545e-01 | 0.658 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.798418e-01 | 0.745 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.396275e-01 | 0.620 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.486609e-01 | 0.828 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.708282e-01 | 0.767 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.477478e-01 | 0.606 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.625117e-01 | 0.789 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.254077e-01 | 0.902 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.882896e-01 | 0.725 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.254077e-01 | 0.902 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.632798e-01 | 0.787 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.196075e-01 | 0.658 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.436520e-01 | 0.843 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.363356e-01 | 0.865 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.625117e-01 | 0.789 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.205381e-01 | 0.657 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.754023e-01 | 0.756 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.615535e-01 | 0.792 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.354660e-01 | 0.628 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.625117e-01 | 0.789 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.089953e-01 | 0.680 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.708282e-01 | 0.767 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.458972e-01 | 0.836 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.862232e-01 | 0.730 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.655425e-01 | 0.781 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.293037e-01 | 0.640 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.076805e-01 | 0.683 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.708282e-01 | 0.767 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.479921e-01 | 0.606 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.521304e-01 | 0.598 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.524656e-01 | 0.598 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.524656e-01 | 0.598 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.524656e-01 | 0.598 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.549892e-01 | 0.593 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.549892e-01 | 0.593 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.590075e-01 | 0.587 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.704756e-01 | 0.568 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.704756e-01 | 0.568 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.704756e-01 | 0.568 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.712301e-01 | 0.567 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.712301e-01 | 0.567 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.717609e-01 | 0.566 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.717609e-01 | 0.566 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 2.717609e-01 | 0.566 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.717609e-01 | 0.566 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.727010e-01 | 0.564 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.727010e-01 | 0.564 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.727010e-01 | 0.564 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.727010e-01 | 0.564 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.727010e-01 | 0.564 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.727010e-01 | 0.564 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.727010e-01 | 0.564 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.727010e-01 | 0.564 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.727010e-01 | 0.564 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.727010e-01 | 0.564 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.727010e-01 | 0.564 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.727010e-01 | 0.564 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.727010e-01 | 0.564 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.727010e-01 | 0.564 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.727010e-01 | 0.564 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.727010e-01 | 0.564 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.748865e-01 | 0.561 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 2.748865e-01 | 0.561 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.748865e-01 | 0.561 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.755662e-01 | 0.560 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.755662e-01 | 0.560 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.755662e-01 | 0.560 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.755662e-01 | 0.560 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.755662e-01 | 0.560 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.755662e-01 | 0.560 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.836939e-01 | 0.547 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.836939e-01 | 0.547 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.852007e-01 | 0.545 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.867828e-01 | 0.542 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.867828e-01 | 0.542 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.867828e-01 | 0.542 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.867828e-01 | 0.542 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.867828e-01 | 0.542 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.867828e-01 | 0.542 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.867828e-01 | 0.542 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.867828e-01 | 0.542 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.867828e-01 | 0.542 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.867828e-01 | 0.542 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.867828e-01 | 0.542 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.867828e-01 | 0.542 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.867828e-01 | 0.542 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.867828e-01 | 0.542 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.912992e-01 | 0.536 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.918768e-01 | 0.535 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.925627e-01 | 0.534 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.937392e-01 | 0.532 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.950885e-01 | 0.530 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.950885e-01 | 0.530 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.989921e-01 | 0.524 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.989921e-01 | 0.524 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.989921e-01 | 0.524 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.989921e-01 | 0.524 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.990549e-01 | 0.524 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.990549e-01 | 0.524 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.001435e-01 | 0.523 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.046759e-01 | 0.516 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.078403e-01 | 0.512 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.078403e-01 | 0.512 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.078634e-01 | 0.512 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.078634e-01 | 0.512 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.078634e-01 | 0.512 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.089059e-01 | 0.510 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.130354e-01 | 0.504 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.136787e-01 | 0.504 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.155264e-01 | 0.501 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.155264e-01 | 0.501 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.255883e-01 | 0.487 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.255883e-01 | 0.487 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.255883e-01 | 0.487 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.255883e-01 | 0.487 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.255883e-01 | 0.487 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.255883e-01 | 0.487 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.277804e-01 | 0.484 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.335838e-01 | 0.477 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.347054e-01 | 0.475 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.349881e-01 | 0.475 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.447151e-01 | 0.463 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.459490e-01 | 0.461 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.459490e-01 | 0.461 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.459490e-01 | 0.461 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.459490e-01 | 0.461 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.459490e-01 | 0.461 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.459490e-01 | 0.461 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.459490e-01 | 0.461 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.459490e-01 | 0.461 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.459490e-01 | 0.461 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.459490e-01 | 0.461 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.459490e-01 | 0.461 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.464045e-01 | 0.460 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.464045e-01 | 0.460 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.464045e-01 | 0.460 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.505030e-01 | 0.455 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.505030e-01 | 0.455 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.564842e-01 | 0.448 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.564842e-01 | 0.448 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.568457e-01 | 0.448 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.625475e-01 | 0.441 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.633050e-01 | 0.440 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.638147e-01 | 0.439 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.638147e-01 | 0.439 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.638147e-01 | 0.439 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 3.638147e-01 | 0.439 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.638147e-01 | 0.439 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.638147e-01 | 0.439 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.638147e-01 | 0.439 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.638147e-01 | 0.439 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.638147e-01 | 0.439 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.638147e-01 | 0.439 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.638147e-01 | 0.439 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.638147e-01 | 0.439 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.638147e-01 | 0.439 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.675082e-01 | 0.435 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.701971e-01 | 0.432 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.701971e-01 | 0.432 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.701971e-01 | 0.432 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.703051e-01 | 0.431 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.721659e-01 | 0.429 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.733581e-01 | 0.428 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.742457e-01 | 0.427 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.744885e-01 | 0.427 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.746013e-01 | 0.426 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.776004e-01 | 0.423 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.799997e-01 | 0.420 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.819440e-01 | 0.418 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.819440e-01 | 0.418 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.845651e-01 | 0.415 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.846720e-01 | 0.415 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.850154e-01 | 0.415 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.850154e-01 | 0.415 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.850154e-01 | 0.415 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.939278e-01 | 0.405 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.983386e-01 | 0.400 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.983386e-01 | 0.400 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.006561e-01 | 0.397 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.011855e-01 | 0.397 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.011855e-01 | 0.397 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.011855e-01 | 0.397 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.011855e-01 | 0.397 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.011855e-01 | 0.397 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.011855e-01 | 0.397 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.011855e-01 | 0.397 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 4.015336e-01 | 0.396 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.018134e-01 | 0.396 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.019628e-01 | 0.396 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.110083e-01 | 0.386 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.118239e-01 | 0.385 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.118239e-01 | 0.385 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.118239e-01 | 0.385 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.118239e-01 | 0.385 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.118239e-01 | 0.385 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.169571e-01 | 0.380 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.175152e-01 | 0.379 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.175152e-01 | 0.379 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.175152e-01 | 0.379 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.190044e-01 | 0.378 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.191989e-01 | 0.378 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.357193e-01 | 0.361 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.374852e-01 | 0.359 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.374852e-01 | 0.359 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.374852e-01 | 0.359 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.374852e-01 | 0.359 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.408845e-01 | 0.356 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 4.408845e-01 | 0.356 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.410406e-01 | 0.356 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.410406e-01 | 0.356 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.410406e-01 | 0.356 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.463018e-01 | 0.350 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.500631e-01 | 0.347 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 4.516881e-01 | 0.345 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.526619e-01 | 0.344 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.561563e-01 | 0.341 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.561563e-01 | 0.341 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.567940e-01 | 0.340 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.596836e-01 | 0.338 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.596836e-01 | 0.338 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.599116e-01 | 0.337 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.639675e-01 | 0.334 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.682810e-01 | 0.329 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.683150e-01 | 0.329 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.683150e-01 | 0.329 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.683150e-01 | 0.329 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.683150e-01 | 0.329 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.683150e-01 | 0.329 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.710675e-01 | 0.327 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.710675e-01 | 0.327 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.710675e-01 | 0.327 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.710675e-01 | 0.327 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.710675e-01 | 0.327 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.710675e-01 | 0.327 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 4.710675e-01 | 0.327 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.725506e-01 | 0.326 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.725506e-01 | 0.326 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.725506e-01 | 0.326 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.725506e-01 | 0.326 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.725506e-01 | 0.326 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.744312e-01 | 0.324 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.744312e-01 | 0.324 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.802953e-01 | 0.318 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.867029e-01 | 0.313 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 4.867029e-01 | 0.313 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.884561e-01 | 0.311 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.884561e-01 | 0.311 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.884561e-01 | 0.311 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.925254e-01 | 0.308 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.949763e-01 | 0.305 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.949763e-01 | 0.305 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.955163e-01 | 0.305 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.062623e-01 | 0.296 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.062623e-01 | 0.296 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.062623e-01 | 0.296 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.062623e-01 | 0.296 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.062623e-01 | 0.296 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.062623e-01 | 0.296 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.062623e-01 | 0.296 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.062623e-01 | 0.296 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.062623e-01 | 0.296 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.062623e-01 | 0.296 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.078526e-01 | 0.294 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.090361e-01 | 0.293 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.090361e-01 | 0.293 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.090361e-01 | 0.293 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.195290e-01 | 0.284 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.197375e-01 | 0.284 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.209513e-01 | 0.283 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.209513e-01 | 0.283 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.209513e-01 | 0.283 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 5.209513e-01 | 0.283 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 5.210035e-01 | 0.283 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.243469e-01 | 0.280 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.243469e-01 | 0.280 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.243469e-01 | 0.280 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.243469e-01 | 0.280 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.243469e-01 | 0.280 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.243469e-01 | 0.280 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.243469e-01 | 0.280 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.243469e-01 | 0.280 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.243469e-01 | 0.280 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.243469e-01 | 0.280 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.243469e-01 | 0.280 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.243469e-01 | 0.280 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.243469e-01 | 0.280 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.243469e-01 | 0.280 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.243469e-01 | 0.280 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.309187e-01 | 0.275 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.309187e-01 | 0.275 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.309187e-01 | 0.275 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.333961e-01 | 0.273 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.352835e-01 | 0.271 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.354802e-01 | 0.271 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.385371e-01 | 0.269 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.385371e-01 | 0.269 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.385371e-01 | 0.269 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.385371e-01 | 0.269 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.385371e-01 | 0.269 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.387802e-01 | 0.269 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.387802e-01 | 0.269 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.387802e-01 | 0.269 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.387802e-01 | 0.269 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.449081e-01 | 0.264 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.461796e-01 | 0.263 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.474650e-01 | 0.262 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.481963e-01 | 0.261 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.481963e-01 | 0.261 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.481963e-01 | 0.261 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.625137e-01 | 0.250 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.663661e-01 | 0.247 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.663661e-01 | 0.247 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.669837e-01 | 0.246 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.669837e-01 | 0.246 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.693226e-01 | 0.245 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.693226e-01 | 0.245 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 5.706129e-01 | 0.244 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.722624e-01 | 0.242 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.722624e-01 | 0.242 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.722624e-01 | 0.242 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.722624e-01 | 0.242 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.722624e-01 | 0.242 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.722624e-01 | 0.242 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.722624e-01 | 0.242 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.722624e-01 | 0.242 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.722624e-01 | 0.242 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.722624e-01 | 0.242 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.722624e-01 | 0.242 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.722624e-01 | 0.242 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.722624e-01 | 0.242 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.722624e-01 | 0.242 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.722624e-01 | 0.242 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.722624e-01 | 0.242 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.731698e-01 | 0.242 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.761593e-01 | 0.239 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.792885e-01 | 0.237 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.813330e-01 | 0.236 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.813330e-01 | 0.236 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.855536e-01 | 0.232 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.886122e-01 | 0.230 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.934719e-01 | 0.227 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.942134e-01 | 0.226 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.942134e-01 | 0.226 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.976174e-01 | 0.224 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.985912e-01 | 0.223 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.985912e-01 | 0.223 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.985912e-01 | 0.223 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.985912e-01 | 0.223 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.985912e-01 | 0.223 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.001495e-01 | 0.222 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.009710e-01 | 0.221 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.125086e-01 | 0.213 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.125086e-01 | 0.213 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.131897e-01 | 0.212 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.131897e-01 | 0.212 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.136334e-01 | 0.212 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.153535e-01 | 0.211 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.153535e-01 | 0.211 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.153535e-01 | 0.211 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.153535e-01 | 0.211 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.153535e-01 | 0.211 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.153535e-01 | 0.211 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.153535e-01 | 0.211 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.153535e-01 | 0.211 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.153535e-01 | 0.211 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.153535e-01 | 0.211 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.153535e-01 | 0.211 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.153535e-01 | 0.211 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.153535e-01 | 0.211 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.153535e-01 | 0.211 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.153535e-01 | 0.211 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.153535e-01 | 0.211 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.169533e-01 | 0.210 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.263361e-01 | 0.203 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.263361e-01 | 0.203 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.263361e-01 | 0.203 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.263361e-01 | 0.203 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.263361e-01 | 0.203 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.263361e-01 | 0.203 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.263361e-01 | 0.203 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.279240e-01 | 0.202 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.296063e-01 | 0.201 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.323030e-01 | 0.199 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.323030e-01 | 0.199 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.323030e-01 | 0.199 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.388135e-01 | 0.195 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.413761e-01 | 0.193 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.481373e-01 | 0.188 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.525673e-01 | 0.185 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.525673e-01 | 0.185 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.525673e-01 | 0.185 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.525673e-01 | 0.185 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.541059e-01 | 0.184 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.541059e-01 | 0.184 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.541059e-01 | 0.184 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.541059e-01 | 0.184 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.541059e-01 | 0.184 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.541059e-01 | 0.184 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.541059e-01 | 0.184 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.541059e-01 | 0.184 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.541059e-01 | 0.184 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.541059e-01 | 0.184 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.541059e-01 | 0.184 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.597827e-01 | 0.181 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.597827e-01 | 0.181 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.620054e-01 | 0.179 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.638881e-01 | 0.178 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 6.686590e-01 | 0.175 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.686590e-01 | 0.175 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.746756e-01 | 0.171 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.750216e-01 | 0.171 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.756353e-01 | 0.170 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.773081e-01 | 0.169 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.773081e-01 | 0.169 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.773081e-01 | 0.169 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.773081e-01 | 0.169 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.773081e-01 | 0.169 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.777475e-01 | 0.169 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.791791e-01 | 0.168 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.798566e-01 | 0.168 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.798566e-01 | 0.168 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.798566e-01 | 0.168 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.798566e-01 | 0.168 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.798566e-01 | 0.168 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.822429e-01 | 0.166 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.866330e-01 | 0.163 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.886996e-01 | 0.162 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.889561e-01 | 0.162 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.889561e-01 | 0.162 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.889561e-01 | 0.162 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.889561e-01 | 0.162 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.889561e-01 | 0.162 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.889561e-01 | 0.162 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.889561e-01 | 0.162 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.889561e-01 | 0.162 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.889561e-01 | 0.162 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.889561e-01 | 0.162 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.889561e-01 | 0.162 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.889561e-01 | 0.162 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.889561e-01 | 0.162 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.889561e-01 | 0.162 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.889561e-01 | 0.162 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.889561e-01 | 0.162 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.889561e-01 | 0.162 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.889561e-01 | 0.162 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.889561e-01 | 0.162 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 6.990368e-01 | 0.155 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.990368e-01 | 0.155 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.990368e-01 | 0.155 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.005926e-01 | 0.155 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.005926e-01 | 0.155 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.005926e-01 | 0.155 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.005926e-01 | 0.155 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.005926e-01 | 0.155 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.005926e-01 | 0.155 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.077359e-01 | 0.150 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.137454e-01 | 0.146 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.139938e-01 | 0.146 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.173304e-01 | 0.144 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.184057e-01 | 0.144 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 7.184057e-01 | 0.144 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.202968e-01 | 0.142 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.202968e-01 | 0.142 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.202968e-01 | 0.142 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.202968e-01 | 0.142 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.202968e-01 | 0.142 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.202968e-01 | 0.142 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.202968e-01 | 0.142 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.202968e-01 | 0.142 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.202968e-01 | 0.142 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.202968e-01 | 0.142 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.202968e-01 | 0.142 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.202968e-01 | 0.142 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.224629e-01 | 0.141 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.224629e-01 | 0.141 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.224629e-01 | 0.141 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.224629e-01 | 0.141 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.224629e-01 | 0.141 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.224629e-01 | 0.141 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.224629e-01 | 0.141 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.224629e-01 | 0.141 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.263576e-01 | 0.139 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.266806e-01 | 0.139 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.266806e-01 | 0.139 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.266806e-01 | 0.139 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.266806e-01 | 0.139 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.266806e-01 | 0.139 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.266806e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.337062e-01 | 0.134 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.337062e-01 | 0.134 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.347489e-01 | 0.134 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.357119e-01 | 0.133 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.357119e-01 | 0.133 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.391999e-01 | 0.131 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.391999e-01 | 0.131 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.429676e-01 | 0.129 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.429676e-01 | 0.129 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.429676e-01 | 0.129 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.429676e-01 | 0.129 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.429676e-01 | 0.129 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.429676e-01 | 0.129 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.429676e-01 | 0.129 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.437078e-01 | 0.129 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.483721e-01 | 0.126 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.484813e-01 | 0.126 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.484813e-01 | 0.126 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.484813e-01 | 0.126 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.484813e-01 | 0.126 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.484813e-01 | 0.126 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.484813e-01 | 0.126 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.484813e-01 | 0.126 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.484813e-01 | 0.126 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.484813e-01 | 0.126 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.484813e-01 | 0.126 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.484813e-01 | 0.126 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.513039e-01 | 0.124 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.513039e-01 | 0.124 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.513039e-01 | 0.124 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.529572e-01 | 0.123 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.529572e-01 | 0.123 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 7.575413e-01 | 0.121 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.616817e-01 | 0.118 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.621598e-01 | 0.118 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.621598e-01 | 0.118 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.621598e-01 | 0.118 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.621598e-01 | 0.118 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.624112e-01 | 0.118 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.624112e-01 | 0.118 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.631652e-01 | 0.117 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.670258e-01 | 0.115 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.670258e-01 | 0.115 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.738273e-01 | 0.111 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.738273e-01 | 0.111 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.738273e-01 | 0.111 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.738273e-01 | 0.111 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.738273e-01 | 0.111 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.738273e-01 | 0.111 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.738273e-01 | 0.111 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.738273e-01 | 0.111 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.742733e-01 | 0.111 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.742733e-01 | 0.111 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.758328e-01 | 0.110 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.758328e-01 | 0.110 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.759408e-01 | 0.110 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.800957e-01 | 0.108 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.800957e-01 | 0.108 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.800957e-01 | 0.108 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.800957e-01 | 0.108 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.819242e-01 | 0.107 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.819242e-01 | 0.107 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.819242e-01 | 0.107 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.846875e-01 | 0.105 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.851451e-01 | 0.105 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.869531e-01 | 0.104 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.886487e-01 | 0.103 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.960266e-01 | 0.099 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.966204e-01 | 0.099 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.966204e-01 | 0.099 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.966204e-01 | 0.099 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.966204e-01 | 0.099 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.966204e-01 | 0.099 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.968337e-01 | 0.099 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.968337e-01 | 0.099 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.968337e-01 | 0.099 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.968337e-01 | 0.099 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.968337e-01 | 0.099 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.968337e-01 | 0.099 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.968337e-01 | 0.099 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.008711e-01 | 0.096 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.013622e-01 | 0.096 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.052846e-01 | 0.094 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.124328e-01 | 0.090 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.169975e-01 | 0.088 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.171178e-01 | 0.088 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.171178e-01 | 0.088 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.171178e-01 | 0.088 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.171178e-01 | 0.088 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.171178e-01 | 0.088 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.171178e-01 | 0.088 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.171178e-01 | 0.088 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.171178e-01 | 0.088 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.171178e-01 | 0.088 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.171178e-01 | 0.088 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.171178e-01 | 0.088 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.171178e-01 | 0.088 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.171178e-01 | 0.088 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.171178e-01 | 0.088 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.171178e-01 | 0.088 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.171178e-01 | 0.088 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.171178e-01 | 0.088 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.171178e-01 | 0.088 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.219462e-01 | 0.085 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.233635e-01 | 0.084 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.269527e-01 | 0.083 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.269527e-01 | 0.083 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.269527e-01 | 0.083 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.279830e-01 | 0.082 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.315883e-01 | 0.080 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.338177e-01 | 0.079 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.338177e-01 | 0.079 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.344811e-01 | 0.079 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.355504e-01 | 0.078 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.355504e-01 | 0.078 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.355504e-01 | 0.078 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.355504e-01 | 0.078 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.355504e-01 | 0.078 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.355504e-01 | 0.078 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.383143e-01 | 0.077 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.404523e-01 | 0.075 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.404523e-01 | 0.075 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.404523e-01 | 0.075 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.404523e-01 | 0.075 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.450011e-01 | 0.073 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.450011e-01 | 0.073 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.459914e-01 | 0.073 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.521262e-01 | 0.069 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.521262e-01 | 0.069 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.521262e-01 | 0.069 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.521262e-01 | 0.069 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.521262e-01 | 0.069 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.521262e-01 | 0.069 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.521262e-01 | 0.069 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.521262e-01 | 0.069 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.521262e-01 | 0.069 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.521297e-01 | 0.069 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.529897e-01 | 0.069 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.529897e-01 | 0.069 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.529897e-01 | 0.069 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.529897e-01 | 0.069 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.555252e-01 | 0.068 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.646218e-01 | 0.063 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.646218e-01 | 0.063 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.646218e-01 | 0.063 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.670320e-01 | 0.062 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.670320e-01 | 0.062 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.670320e-01 | 0.062 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.670320e-01 | 0.062 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.670320e-01 | 0.062 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.670320e-01 | 0.062 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.670320e-01 | 0.062 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.670320e-01 | 0.062 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.670320e-01 | 0.062 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.684547e-01 | 0.061 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.710420e-01 | 0.060 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.754036e-01 | 0.058 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.754036e-01 | 0.058 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.754036e-01 | 0.058 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.804362e-01 | 0.055 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.804362e-01 | 0.055 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.804362e-01 | 0.055 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.804362e-01 | 0.055 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.804362e-01 | 0.055 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.804362e-01 | 0.055 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.804362e-01 | 0.055 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.853882e-01 | 0.053 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.853882e-01 | 0.053 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.868003e-01 | 0.052 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.869044e-01 | 0.052 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.916017e-01 | 0.050 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.916017e-01 | 0.050 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.924898e-01 | 0.049 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.924898e-01 | 0.049 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.924898e-01 | 0.049 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.924898e-01 | 0.049 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.924898e-01 | 0.049 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.924898e-01 | 0.049 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.939938e-01 | 0.049 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.946269e-01 | 0.048 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.946269e-01 | 0.048 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.946269e-01 | 0.048 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.983830e-01 | 0.047 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.031684e-01 | 0.044 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.031684e-01 | 0.044 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.031684e-01 | 0.044 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.033289e-01 | 0.044 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.033289e-01 | 0.044 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.033289e-01 | 0.044 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.033289e-01 | 0.044 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.033289e-01 | 0.044 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.071845e-01 | 0.042 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.089557e-01 | 0.041 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.109407e-01 | 0.041 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.110233e-01 | 0.040 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.110594e-01 | 0.040 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.130758e-01 | 0.039 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.130758e-01 | 0.039 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.130758e-01 | 0.039 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.130758e-01 | 0.039 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.130758e-01 | 0.039 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.130758e-01 | 0.039 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.131212e-01 | 0.039 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.132171e-01 | 0.039 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.193965e-01 | 0.036 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.218404e-01 | 0.035 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.218404e-01 | 0.035 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.218404e-01 | 0.035 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.218404e-01 | 0.035 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.242425e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.250648e-01 | 0.034 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.252273e-01 | 0.034 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.252273e-01 | 0.034 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.292685e-01 | 0.032 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.297218e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.297218e-01 | 0.032 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.302841e-01 | 0.031 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.312609e-01 | 0.031 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.312609e-01 | 0.031 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.325628e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.354942e-01 | 0.029 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.368089e-01 | 0.028 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.368089e-01 | 0.028 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.368089e-01 | 0.028 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.368089e-01 | 0.028 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.368089e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.368089e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.369698e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.369698e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.369698e-01 | 0.028 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.384266e-01 | 0.028 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.422269e-01 | 0.026 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.431816e-01 | 0.025 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.431816e-01 | 0.025 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.461287e-01 | 0.024 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.470651e-01 | 0.024 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.481830e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.489121e-01 | 0.023 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.489121e-01 | 0.023 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.489121e-01 | 0.023 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.515154e-01 | 0.022 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.540648e-01 | 0.020 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.540648e-01 | 0.020 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.540648e-01 | 0.020 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.556069e-01 | 0.020 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.559085e-01 | 0.020 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.567904e-01 | 0.019 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.586982e-01 | 0.018 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.586982e-01 | 0.018 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.586982e-01 | 0.018 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.586982e-01 | 0.018 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.586982e-01 | 0.018 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.593666e-01 | 0.018 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.596563e-01 | 0.018 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.603200e-01 | 0.018 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.603200e-01 | 0.018 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.603200e-01 | 0.018 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.605429e-01 | 0.017 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.627651e-01 | 0.016 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.628198e-01 | 0.016 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.628198e-01 | 0.016 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.628644e-01 | 0.016 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.628644e-01 | 0.016 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.628644e-01 | 0.016 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.628644e-01 | 0.016 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.628644e-01 | 0.016 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.631084e-01 | 0.016 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.637388e-01 | 0.016 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.652296e-01 | 0.015 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.666106e-01 | 0.015 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.666106e-01 | 0.015 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.666106e-01 | 0.015 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 9.671626e-01 | 0.015 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.688994e-01 | 0.014 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.688994e-01 | 0.014 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.688994e-01 | 0.014 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.699791e-01 | 0.013 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 9.715680e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.730079e-01 | 0.012 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.730079e-01 | 0.012 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.737708e-01 | 0.012 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.750598e-01 | 0.011 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.757313e-01 | 0.011 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.781801e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.781801e-01 | 0.010 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.783128e-01 | 0.010 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.792783e-01 | 0.009 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.800388e-01 | 0.009 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.819182e-01 | 0.008 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.819182e-01 | 0.008 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.823616e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.841417e-01 | 0.007 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.847455e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.851170e-01 | 0.007 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.851170e-01 | 0.007 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.851170e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.851986e-01 | 0.006 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.856528e-01 | 0.006 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.857422e-01 | 0.006 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.857422e-01 | 0.006 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.857422e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.857422e-01 | 0.006 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.859600e-01 | 0.006 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.862588e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.871813e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.871813e-01 | 0.006 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.885696e-01 | 0.005 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.896386e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.899523e-01 | 0.004 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.899523e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.904177e-01 | 0.004 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.904997e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.906798e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.906845e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.906845e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.906845e-01 | 0.004 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.907646e-01 | 0.004 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.915132e-01 | 0.004 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.916250e-01 | 0.004 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.916250e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.918015e-01 | 0.004 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.932308e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.932308e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.932308e-01 | 0.003 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.932308e-01 | 0.003 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.934524e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.940370e-01 | 0.003 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.945288e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.956850e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.960247e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.960247e-01 | 0.002 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.964262e-01 | 0.002 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.964262e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.966821e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.971117e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.974035e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.974631e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.976658e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.977980e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.979017e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.980802e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.981137e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.981137e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.984161e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.987480e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.988548e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.988659e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.989208e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.989208e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.989378e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.990046e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.990236e-01 | 0.000 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.991957e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.992239e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993312e-01 | 0.000 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.993501e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.994112e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.994749e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995192e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.995341e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996572e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996918e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.996918e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.996936e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.997250e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.997250e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.997510e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997762e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.997762e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.997867e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997927e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998113e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998130e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998539e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998744e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998841e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999424e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999441e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999614e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999803e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999810e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999820e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999830e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999841e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999861e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999879e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999887e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999887e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999887e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999897e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999909e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999921e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999950e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999975e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999975e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999979e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999979e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999981e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999987e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999990e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999996e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |